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ABSTRACT

The pathogenesis of equine herpesvirus type 1 (EHV-1) and
type 2 (EHV-2) respiratory infection was studied in cell and
organ cultures by infectivity assays following experimental
infections (growth kinetics), and by light, scanning and
transmission electron microscopy.

The cell cultures included

fetal donkey and pony alveolar macrophages (FDAM/FPAM), fetal
equine kidney (FEK), rabbit kidney (LLC-RK^), and african green
monkey kidney (VERO) cells. Organ cultures were derived from
respiratory tissues (nasal, tracheal and pharyngeal mucosae) of
seronegative donkey (FlDl) and pony (F1M1) fetuses, and of a
seropositive adult pony (Al).
In the cell cultures, EHV-1 multiplied and produced
cytopathic effects (CPE) as early as 6 hours post inoculation
(HPI) in LLC-RK^ cells characterized mainly by cell rounding
and lysis.

EHV-2 multiplied more slowly and produced CPE as

early as 48 HPI in LLC-RK^ FDAM, and FEK cells.

The CPE

caused by EHV-2 in the various cultures consisted principally
of rounding of cells and syncytia formation.

In EHV-2 infected

FPAM, the appearance of CPE was preceeded by changes in
organization of microfilaments and microtubules.
In the organ cultures morphogenesis of EHV-2 was observed
in the nucleus of infected F1M1 nasal epithelial cells.

All

the cultures supported the growth of EHV-1 and EHV-2 except
F1M1 pharyngeal and Al nasal cultures which were non permissive

x

for EHV-2.

EHV-1 and EHV-2 were recovered from infected FlDl

cultures for 10 and 30 days, respectively.
Cytopathic alterations produced by EHV-1 and EHV-2 were
observed in the epithelial layer of organ cultures and were
characterized by cessation of ciliary activity, rounding and
shedding of ciliated and non ciliated cells.
was most extensive in EHV-1 infected cultures.

Epithelial damage

GENERAL INTRODUCTION

Three main groups of herpesviruses affect horses and these
have been called equine herpesvirus type 1 (EHV-1), type 2
(EHV-2), and type 3 (EHV-3).

The equine herpesviruses (EHVs) are

of both economic and research interest.

Infection of horses by

EHV-1 strains, for example, results in heavy economic losses to
the equine industry in the form of abortions and birth of weak and
moribund foals.

For research purposes, the EHVs may provide a

model system for studying the varying clinical and biological
consequences of herpesvirus infections in man.

The various

clinical signs of EHV infections in horses appear similar in many
instances to those of Herpes simplex and cytomegalovirus
infections in man.

The signs in both cases may vary from

subclinical infection to localized lesions on the genitalia to
severe generalized disease.
EHV-1 and EHV-3 have received much attention mainly because
of their association with overt clinical disease.

In contrast,

only little is known about the pathogenicity of EHV-2 in horses.
In the last decade, EHV-2 has been isolated from cases of
pharyngitis in young and old horses.

Also losses due to EHV-2

respiratory infection have been recorded among foals.

Despite

increasing reports of association of EHV-2 with equine disease,
the pathogenesis of EHV-2 infections remains to be determined.
Information about the pathogenic mechanisms of EHV-2 is

1

2

fundamental to understanding of the nature and control of EHV-2
disease.
This study Investigates the pathogenic potential of EHV-2 in
equine respiratory disease by using equine respiratory organ
cultures and a variety of cell cultures.
Since the completion of this work the designation for type 1
equine herpesvirus involved in equine respiratory tract infections
has been changed.

EHV-1, strain KyD, (reported and used in the

study) is currently designated EHV-4.

The designation EHV-2 for

slowly growing or slowly cytopathic equine herpesvirus (also used
in the study) remains unchanged.

LITERATURE REVIEW

The Equine Herpesviruses (EHVs)

SIGNIFICANCE OF THE EHVs
Three antigenically distinct types of herpesviruses are known
to

naturally infect the horse and other members of the equine

family and have been designated equine herpesvirus type 1 (EHV-1),
also referred to as equine abortion or rhinopneumonltis virus),
type 2 (EHV-2, also called slowly cytopathic or equine
cytomegalovirus), and type 3 (EHV-3, or equine coital exanthema
virus).

1 2

Interest.

*

The EHVs are of considerable economic and research
Economic losses caused by EHV-1 infection are

substantial because of abortion and also respiratory disease of
3 4
weanlings, yearlings, and race horses. ’

In regard to the

3

general field of comparative pathology and medicine, EHVs have
been used as a model system for studying the varied biological
consequences of herpesvirus infections.

GENERAL PROPERTIES OF THE EHVs
Virion morphology
The structure of equine and other herpesviruses has been
d e s c r i b e d . ^ .8.9,10

^ eqUine viruses are similar in

structure to each other and to herpesviruses of other species.
They possess an

internal DNA-containing core enclosed within an

icosahedral capsid to form a nucleocapsid; this structure is
surrounded by a loose outer envelope which is derived from the
modified cellular nuclear membrane.
virion ranges from 150 to 170nm.

The diameter of the enveloped

The nucleocapsid is approxi

mately lOOnm in diameter and consists of 162 morphological
subunits called capsomeres.

The capsomeres, about lOnm across and

15nm in length, project outwards and are radially displaced from
one another.

Intercapsomeric fibrils 2nm in diameter have been

reported to link adjacent capsomeres.
Roizman et al 13 described 6 features of herpesvirus structure
in electron micrographs of thin sections of infected cells.

They

are: 1) a core 25-30nm in diameter, 2) an inner capsid 8-10nm
thick, 3) a middle capsid 15nm thick, 4) an outer capsid 12.5nm
thick, 5) an inner envelope lOnm thick and 6) an outer envelope
approximately 20nm thick.

Spikelike projections 8-10nm in length

are spaced 5nm apart on the envelope surface. 14
play a role in virus attachment.

The spikes may

Many species of nucleocapsids

have been reported in herpesvirus-infected cells.^

Three of

these were observed in various cells infected with the
EHVs.^’^ ’^

They are: 1) empty capsids, 2) capsids with an

electron-lucent, cross-shaped core, and 3) capsids with an
electron dense core representing mature nucleocapsids.
Virus multiplication
Virus multiplication among the EHVs occurs in the nucleus
where their maturing nucleocapsids may give rise to
paracrystalline arrays.^

The relationship of the viral

crystalloid clusters to inclusion body formation has been
established.^
studied.

The early events of EHV-1 infection have been

Virus attachment is rapid and temperature independent,

and is readily inhibited by heparin and sulfated agar
polysaccharides.^’^

Both intact and deenveloped EHV-1 enter

cells by a viropexis mechanism in which particles are engulfed by
pseudopodia which either surround the virus and fuse with the cell
membrane or fuse to other pseudopodia, forming fusion vacuoles
containing from one to numerous viral particles.

18

In fetal equine kidney (FEK) cells EHV-1 was reported to have
an eclipse period of 6 hours, and maximum level of cell-associated
virus was attained by 20 to 24 hours while maximum level of
extracellular EHV-1 was reached about 2 hours later.*

In the same

article, the author observed that EHV-2 had an eclipse period of
18 hours in FEK cells and that maximal levels of cell-associated
virus were attained after 96 hours.
is similar to that of EHV-1.

The growth pattern of EHV-3

Under one-step growth conditions, an

5

eclipse period of 8 hours was reported for EHV-3.

20

In the same

report peak EHV-3 titers were reached in 22-24 hours.
Recently Wharton et a l ^

found that EHV-2 had eclipse

periods of 24 to 48 hours in LLC-RK^ (a continuous rabbit kidney
cell line) and KyED (a fetal equine diploid cell strain) cells
respectively.

Maximum virus titers were reached at 96-120 hours

post-inoculation.

The authors noted that approximately 50% of

total infectious EHV-2 remained cell-associated in infected KyED
cells, while 20-40% of the infectious virus remained cell-associ
ated in LLC-RKj cells.

The authors observed 2 independent

processes of envelopment.

In the first, core-containing capsids

interacted with the nuclear membrane and budded outward to obtain
an envelope.

In the second process, convolutions of nuclear

membrane appeared to invaginate into the

nuclear space and react

with the capsid.
Two mechanisms have been proposed for the release of
herpesviruses from infected cells.

One involves the virus

travelling in a continuous route from the perinuclear space via
the endoplasmic reticulum to the extracellular space.

21 22 23
’ *

Alternatively, the virus may travel in a discontinuous manner in
vacuoles and be secreted in a manner analogous to other exported
cellular products.

24

Regardless of which mechanism actually

prevails, enveloped virus appears to be protected from direct
contact with the cytoplasm which might contain enzymes or factors
that may be detrimental to the virus.

Intracytoplasmic budding

has also been reported for herpesviruses.*^

6

Genetic and Antigenic Relatedness of the EHVs
Nucleic acid hybridization and restriction endonuclease
fingerprinting are two methods that have been used in studying the
genetic relatedness among viruses.

In the former method, DNA or

RNA of one virus is hybridized to excess DNA of another, either
free in solution or fixed to filters.

Through DNA-DNA

hybridization, 47-48% homology was noted between the DNA of herpes
simplex virus (HSV) type 1 and type 2,
high degree of relatedness.

25

suggesting a relatively

In contrast only 17% homology between

respiratory (R) and abortigenic (F) strains of EHV-1,
to 8.9% between the EHVs were detected.^

26

and 1.0

The presence of

homologous sequences among viruses could indicate a common
ancestral origin or the exchange of genetic information by
recombinational events.
Recently, the R and F strains of EHV-1 were analyzed by the
restriction endonuclease fingerprinting technique.

26

The overall

pattern of R strains were similar but entirely different from the
F strains.

Data from this study together with the hybridization

results suggest that the R and F strains of EHV-1 may represent
entirely distinct stable species.
In serological studies, Plummer

27

found no cross neu

tralization among EHV-1, EHV-2 and HSV-1.

However, there was

cross reactivity between EHV-1 and EHV-2 in the complement
fixation test.

The above observations suggest that EHV-2 and

EHV-1 may share certain group specific but not type specific
antigens.

EHV-1 shares common complement-fixing antigenic

7

determinants with infectious bovine rhinotracheitis virus

28

as

well as with HSV-1,^
Antigenic subtypes have been reported for the EHVs.

American

and Japanese EHV-1 strains had identical complement- fixing
antigens but by serum neutralization two subtypes were
demonstrable.

29

30
Shimuzu et al

provided evidence for the

presence of at least 2 subtypes of EHV-1.
represented by

Subtype 1 was

the American Kentucky-D (Ky-D) strain, and subtype

2 by the Japanese H-45 virus.

In a related report Mayr et al

31

noted that subtype 2 strains, including German, Swiss, Polish and
American (Army 183), were more common in Europe than subtype 1
(Ky-D).

Antigenic heterogeneity has also been reported for EHV-2

1 32 33
strains * *

but only few isolates have been studied.

14

Past

studies on biological properties of EHV-2 have shown that with
increasing cell passage the virus becomes progressively more
cell-associated as reflected by more difficulty in isolation,
slower expression of cytopathology and a lower peak titer of
released virus.*

The greater cell- association is accompanied by

altered antigenicity as measured by neutralization tests.*

On the

basis of the above observations, the possibility of antigenic
drift in EHV-2 was suggested*' but remains unconfirmed.

EQUINE HERPESVIRUS .1 (EHV-1, EQUINE RHINOPNEUMONITIS VIRUS, EQUINE
ABORTION VIRUS, EQUINE "INFLUENZA" VIRUS).
History, Distribution and Incidence:
The first report of equine herpesvirus 1 was by Dimock and
Edwards^’^

in 1932 and 1933 in Kentucky, USA.

The authors de

8

scribed abortion storms among mares in which no bacteria could be
isolated but which could be transmitted by inoculation of mares
with bacteriologically sterile suspensions of aborted fetuses.
The observations of Dimock and Edwards were confirmed first in
Europe

36 38

and subsequently in other parts of the world.

39 40
*

The early investigators of equine virus abortion focused
their attention on lesions found in aborted fetuses as they were
unaware of

the respiratory disease caused by EHV-1.

At that

time, horses that showed signs of respiratory tract infection were
regarded as having contracted equine "influenza" even though true
equine influenza viruses were not isolated until 1958.

39

This

confusion in terminology makes for problems in literature
searching and logical presentations.

In the following I will use

"influenza" to refer to isolates prior to 1958 of probable EHV-1
identity.

In 1941, Manninger and Csontos

41

inoculated mares with

a virus that they had recovered from an aborted fetus and produced
an influenza-like disease.

This led the two investigators to

conclude that abortion was a secondary manifestation of equine
"influenza" infection in pregnant mares.

In the same year Kress

reported an outbreak of virus abortion in Austria.

42

He observed

respiratory signs in eight horses after the abortions had occurred
and also found lung lesions in aborted fetuses.

From these

findings Kress correctly concluded that the abortion virus was
pneumotropic. It is interesting to note however that in
cross-protection trials, Doll and Kintner

43

demonstrated an

immunogenic relationship between the equine "influenza" and
abortion viruses.

In their experiment, inoculation of two

9

seronegative young horses with the Kentucky B strain of abortion
virus resulted in refractivity to subsequent inoculation with the
Army 183 and Grayson 1 strains of equine "influenza" virus.
Antigenic similarity between equine "influenza" and abortion
viruses was also established in the study, as indicated by
reciprocal fixation of complement with antisera and antigens for
the two viruses.
The first experimental clinical observations of the
respiratory phase'of equine virus abortion were reported by Doll
44

et al

in 1953.

Weanling horses inoculated intravenously or

intranasally with the Kentucky-B strain of equine abortion virus
developed a febrile disease accompanied by leukopenia and symptoms
of mild respiratory infection.
It is now established that EHV-1 infection of horses may
result in any of 4 clinical syndromes including respiratory
disease, abortion, perinatal disease, and myeloencephalitis
(discussed further in the next section). Additional recent
investigations using techniques of molecular epidemiology indicate
that two distinct species of EHVs may be involved in the
respiratory and abortion syndromes, and EHV-4 has been a
suggested name for the respiratory forms.

26

The early descriptions of disease caused by EHV-1 called it
epizootic equine abortion or virus abortion of mares.

To

provide a more specific descriptive name and to differentiate it
from the "influenza" and viral arteritis virus, Doll et al

46

suggested the use of the name equine rhinopneumonitis for the
disease and equine rhinopneumonitis virus for the etiological

10

agent.

Subsequently, Plummer ^ proposed the name equine

herpesvirus 1 for equine rhinopneumonitis virus to differentiate
it from equine herpesvirus 2, the LK virus.

Clinical Signs
In a recent review, 4 clinical syndromes were associated with
exposure of horses to EHV-1.

47

They are:

respiratory disease,

abortion, myeloencephalitis, and perinatal disease.

The

respiratory syndrome which is thought to have an incubation period
of 2-10 days occurs mainly in foals, weanlings, and yearlings, and
is characterized by fever, anorexia and serous to
nasal discharge.

mucopurulent

In uncomplicated cases recovery is usually

spontaneous in 5-7 days.

48

However, secondary bacterial invasion

may occur and the affected animals may develop bronchopneumonia.
Mild or subclinical respiratory disease is commonly seen in horses
with antibodies to EHV-1.

EHV-1 infection of the pregnant mare

may lead to fetal infection and subsequent abortion.

After

experimental exposure to the virus, seropositive pregnant mares
abort in 14-120 days without premonitory signs of disease.
Following natural exposure most mares abort at 6-11 months of
gestation although fetuses of all ages are susceptible.

Infected

mares may occasionally also show nervous signs (myeloencephalitis
syndrome) or they may give

birth to weak foals (perinatal syn

drome) . The presenting signs in such foals may include respi
ratory distress, watery, non-fetid diarrhea, and weakness during
the first few weeks of life.

The foals survive until two weeks of

age when signs of secondary bacterial infections become apparent.

11

Pathology
Campbell and Studdert

47

gave a detailed account of the

pathology of the 4 syndromes of EHV-1 disease.
disease is rarely fatal.

EHV-1 respiratory

Deaths, if they occur are due to

overwhelming secondary bacterial infections.

Necrotic lesions may

be present in the respiratory epithelium and lymphoid germinal
centers.

In addition, intranuclear inclusion bodies may be

observed in the affected tissues.

In the abortion syndrome, the

natural route of infection is presumed to be via the upper
respiratory tract, followed by a cell- associated viremia,
resulting in placental transfer and infection of the fetus with
subsequent abortion. 47

Many workers have described the various

lesions in aborted fetuses.

Gross pathological changes consist of

hydrothorax, numerous subcapsular necrotic areas in the liver, and
hemorrhages in the visceral organs.

45

Histologically, necrotic

lesions are found in the lung, liver, and spleen in addition to
widespread hemorrhages and edema.

7

49
Dimock
observed eosinophilic

intranuclear inclusion bodies at the periphery of necrotic lesions
in the liver and lung of aborted fetuses.

However, these

inclusion bodies may disappear following inflammation or
post-mortem autolysis.^

The most consistent lesion observed in

the mare after abortion is an intense perivascular infiltration of
lymphocytes and plasma cells around blood vessels located just
beneath the glandular layer of the endometrium.

47

Prior to

abortion, intravillar necrosis accompanies perivascular cuffing
resulting in complete separation of the allanto-chorion and
uterine endometrium. ^
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In the perinatal disease syndrome, gross lesions are confined
to the respiratory tract and are characterized by edema and
enlargement of the lungs and bronchial lymph nodes and hemorrhages
in the trachea and bronchi.

Microscopic lesions consist of

nonsuppurative inflammatory changes throughout the lower
respiratory tract, eosinophilic intranuclear inclusion bodies
especially in the lungs, and depletion and/or degeneration of
lymphocytes in lymphoid tissues.

In the myeloencephalitis

syndrome, vasculitis appears to be the prominent lesion with
secondary hypoxic degeneration in adjacent neural tissue.

The

frequent failure to isolate virus from nervous tissue in this
syndrome is probably a consequence of virus-antibody complexes,
formed either in vivo or in vitro during the preparation of
tissues for inoculation of cell cultures. 47
Diagnosis
Diagnosis of EHV-1 disease in the past was based on history,
clinical signs and pathological findings.^’"^ Recent methods for
diagnosis of EHV-1 abortions and respiratory tract infections
include virus isolation, serology, histopathology, electron
microscopy, and immunofluorescence microscopy of infected
„ . . 40,48
material.
Epidemiology
Available literature indicates that horses are the natural
hosts of EHV-1 with a high prevalence of viral antibodies of
85-92% in some areas.

51 52
*

Doll and Bryans

53

observed that the

virus may be spread by direct (ingestion or inhalation) or

13

indirect contact.

They observed that mares which aborted late in

pregnancy had been in contact with foals with EHV-1 respiratory
signs.

Alternatively, Campbell and Studdert

epizootic abortion was initiated by
introduced pregnant mare.

47

noted that

abortion in a recently

Further, these authors deduced that the

aborted fetus, membranes, and fluids may be an important source of
infection for mares and that abortion occurs because the strain of
virus is appropriate and the immunity of the mare has diminished
to an extent that allows local virus multiplication with
subsequent viremia and

Bryans

53

transplacental transfer.

Doll and

have suggested that a natural reservoir or a high

incidence of carriers may exist among adult horses.

The possible

role of donkeys as carriers of EHV-1 has not been investigated,
however, previous work by Henning"^ has revealed that donkeys may
be more resistant to EHV-1 infection than horses.
In recent years the epidemiology of EHV-1 infection has
become more complex with the identification of many strains of
EHV-1.

Burrows and Goodridge

54

observed that differences in

virulence occur between those strains of virus which cause
respiratory disease and those associated with abortion outbreaks.
Their in vitro studies indicated that the abortigenic strains had
a wider tissue culture host range than the respiratory strains.
In addition to classification as abortigenic or respiratory
strains, type 1 EHVs have also been characterized as subtype I (if
they were antigenically closely similar to Kentucky D, the
prototype abortigenic strain) and subtype 2 (if they differed

14

40
slightly but consistently from subtype 1 viruses).

The source

of virus, whether from an aborted fetus or from the respiratory
tract of a horse, did not necessarily determine the subtype.
However, majority of isolates from fetuses were subtype 1.

40

Currently, restriction enzyme analysis has been suggested to be
the best available method for distinguishing EHV-1 strains.
Through this technique differentiation has been successfully made
between respiratory(R) and abortigenic(F) strains of EHV-1,
well as between plaque variants of EHV-3.
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Mechanism of persistence of EHV-1
Whether EHV-1 survives in the convalescent animal as a
chronic or latent infection is not clear.

Latent herpesvirus

infections with periodic recrudescences following a variety of
natural and artificial stimuli are recognized in man and some
animals. 47 Seroepidemiological studies indicate that 70-100% of
people over 15 years of age have been exposed to herpes simplex
virus l(HSV-l) but only approximately half of these suffer from
clinical disease with the other half shedding or not shedding
virus in the absence of symptoms.
Latent infectious bovine rhinotracheitis virus infection was
activated in cattle by the administration of corticosteroids but
similar experiments involving EHV-1 in the horse proved to be
inconclusive.

57 58
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In 1978, Burrows and Goodridge

59

provided

indirect evidence for EHV-1 latency by recovering the virus from
the nasal secretions of ponies in an isolated herd.

Neutralizing

antibody (4-fold increase and above) was demonstrated in seven of
eight ponies involved in the study.

15

A number of possible mechanisms of herpesvirus latency have
been postulated.^ In both DNA and RNA viruses, a latent infection
may be established by the integration of the viral genome into
that of the host.

The balance between virus infectivity and

interferon stimulating activity could also contribute to the
development of a latent infection.

Thus, an increase in virus

titer may stimulate infected cells to produce interferon, which in
turn inhibits the multiplication of the virus.

This removes the

stimulus for further production of interferon, and the subsequent
decline of interferon concentration results in multiplication of
the virus.

This again stimulates the cells to produce interferon,

and the cycle continues.

Evidence is accumulating that defective

interfering (DI) particles or mutant viruses could contribute to
the persistence of viral infections in animals and man.^^

Among

the EHVs, EHV-1 has been shown to produce DI particles both in
vivo and in vitro.

61 63
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However, the recovery of defective or

mutant viruses in latently infected animals does not establish
their role in the initial infection and, to date, the evidence for
persistent or latent infections with EHV-1 remains circumstantial.
Immunity
The immunity resulting from EHV-1 infection is of short
duration.

Many horses experience a number of infections during
cO

r j

their lifetime.

Studies by Doll and Bryans

could become reinfected within 3 to 5 months.
was observed by Burrows and Goodridge

64

showed that horses
Such reinfection

to be subclinical and was

thought to be related to the presence of neutralizing antibodies.

16

Burrows and Goodridge

64

showed that ponies with serum neutralizing

antibody titers of greater than 1:24 were resistant to
experimental infection by intranasal exposure to EHV-1.

However,

relatively high serum antibody titers have been observed in some
vaccinated mares that aborted.^
There is no clear understanding of the role of immune
mechanisms in either protection from disease or the pathogenesis
of disease for a herpesvirus of any species.^

Nevertheless, it

has been stated in general that cell mediated immune (CMI)
responses play a central role in the prevention of and recovery
from herpesvirus disease. ^ The results of studies by Gerber et
a l ^ are in agreement with the general statement above.

In their

vaccination studies with modified live EHV-1 vaccine, the authors
found that 6-8 month old horses showed only slight or no increase
in anti EHV-1 serum neutralizing antibody.

However, these same

horses showed a marked increase in the CMI response to EHV-1 as
measured by the lymphocyte transformation test.

In the same study

lymphocytes from pregnant mares showed a decreased sensitivity to
EHV-1 after exposure to virulent EHV-1 while lymphocytes from non
pregnant mares and stallions showed an increase in the
incorporation of tritiated thymidine following stimulation by
EHV-1.

The observed EHV-l-induced depression of CMI response late

in gestation may account for the increased susceptibility of mares
to EHV-1 infection and the subsequent temporally associated
abortions.

It is believed that cytotoxic antibodies or cells

could also participate in restricting virus spread after
infection. ^

Finally, because herpesvirus-infected cells induce

surface cell membrane changes, antibody can bind to these
virus-coded surface antigens and cooperate with various effector
cells (eg macrophages and polymorphonuclear leucoytes) in
antibody-dependent cell-mediated cytotoxicity (ADCC)."^
Two commercially available EHV-1 vaccines (fetal origin)
have been d e s c r i b e d , a R^Hed virus vaccine preparation
(Pneumabort-K, Fort Dodge Laboratories, Iowa) and the

attenuated

live virus vaccine (Rhinomune, Norden Laboratories, Lincoln,
Nebraska). Only the inactivated vaccine is licensed for the
prevention of abortion in mares.

It is also recommended for the

prevention of EHV-1 respiratory disease in young animals.

The

attenuated vaccine is currently licensed only for the prevention
of the EHV-1 respiratory syndrome but it is also being used on
some farms for immunoprophylaxis against EHV-1 abortions in mares.
Live vaccines have to be used with great circumspection as a
possibility always exists for reversion of vaccine virus to
virulence. Subunit vaccines containing EHV-1 envelope components
(glycoprotein fraction) have been observed to protect hamsters
against EHV-1 challenge.^ The potential for the use of this
vaccine in horses as an alternative to the conventional vaccines
is yet to be clearly determined.
Experimental Host Systems
Although members of the family Equidae have been reported as
being the natural hosts of EHV-1, the virus also has a wide
experimental host range with regard to both animal and tissue
culture systems.

Abortions following EHV-1 infection have been
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recorded in guinea pigs.^’"^ EHV-1 has been adapted to suckling
hamsters,^ and has been grown also in fertile eggs.^
The biological properties of EHV-1 were studied in detail
with the advent of tissue culture methods.

The cultivation of

EHV-1 was first made in 1953 in Maitland type tissue culture
systems with tissues of horses.

72

Subsequently the virus was

cultivated in monolayer cultures of various animal tissues.
Studies of Kock

73

indicate that in primary monolayer cultures of

horse kidney, the Army 183 strain of EHV-1 multiplies to peak
titers of 10

7

to 10

8

TOID^/ml whereas the Ky-D strain attains

peak titers of 10"’*^"’ to 10^*® TCID^Q/ml in the same culture
system.

Bagust^ listed 17 primary and 14 continuous cell line

cultures which are susceptible to EHV-1. Bartha

74

made some

observations on the growth and cytopathic expression in tissue
culture adapted and field (native) strains of EHV-1.

Tissue

culture adapted strains multiplied more rapidly than primary
isolates producing extensive degeneration of cultures in 24 to 48
hours versus 3 to 5 days for CPE with field isolates.
The use of organ cultures for the study of virus/cell
interactions is now well established.

O'Niell and Issel^

studied the kinetics of EHV-1 release from fetal equine
respiratory organ cultures.

Initial peak titers were observed

from tracheal cultures (24 hours) but beyond 24 hours virus was
released to higher titers from nasal cultures.

In studies

involving EHV-1 growth in organ cultures of foal trachea, Burrows
and Goodridge

found that EHV-1 strains recovered from the
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respiratory tract were less virulent than those recovered from the
fetus.

Fetal strains grew more rapidly than the respiratory

strains and reached a ten-fold higher peak concentration of virus
over a 5-day growth period.

The authors remarked that monolayer

cultures are not particularly useful for basic studies of cellular
and tissue specificity or the growth of viruses in vivo.

They

suggested that a better estimate of the growth of virus in the
normal host may be obtained in organ cultures and that the slower
growth of EHV-1 respiratory strains compared to that of the fetal
strains in organ cultures of foal trachea could be a reflection of
decreased virulence for the horse.

EQUINE HERPESVIRUS 2 (EHV-2, SLOWLY GROWING OR SLOWLY CYTOPATHIC
EHV, EQUINE CYTOMEGALOVIRUSES)

History, Incidence and Clinical Significance
In 1963 in England, Plummer** reported the isolation of a
herpesvirus from a horse suffering from catarrh.

He found the

virus to be serologically distinct from the classic equine
abortion or rhinopneumonitis virus and proposed that the abortion
virus be called equine herpesvirus 1, and his isolate, also called
the LK virus, equine herpesvirus 2.

Since then equine herpesvirus

2 (EHV-2) strains have reportedly been isolated in many countries
including Japan in 1964,
1967,

7ft
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Switzerland in 1966,

South Africa in 1966,

7Q
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Germany in

United States in 1968,

in 1970,^ and Hungary in 1978.^

ftn

Australia

20

The prevalence of EHV-2 based on serology is very high among
horse populations and may reach 90% in some cases.

83

Infection of

horses with EHV-2 is reported to occur before 4 months of age.
Wilks and Studdert

85
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detected EHV-2 neutralizing antibody in the

serum of 7 mares but not in presuckling serum of their progeny.
Furthermore, they did not isolate EHV-2 from nasal swabs nor from
buffy coat samples obtained from any of the foals at the time of
birth, although the virus was present in the buffy coat cells of 1
mare at parturition.

Thus horses may become infected with EHV-2

postnatally rather than prenatally, and at present no evidence
exists for transplacental transfer of EHV-2.
EHV-2 has been associated with some forms of respiratory
disease and

the virus is frequently recovered from tissues such

as kidney, spleen, testicle and buffy coat cells where its
significance is unknown.*

Some workers recovered EHV-2 from the

nasal cavity of 3 horses for 418 days after experimental
infection.

86

This observation is in marked contrast to the

failure to isolate EHV-1 and EHV-3 for longer than 14 days after
primary infection.*

In another study, EHV-2 antibody in foals

after natural infection persisted for 180 days.

85

These

observations support the statement that once infected a horse
appears to be a life long carrier and a seemingly constant shedder
of EHV-2.*

The apparent ubiquitous nature of EHV-2 makes it

difficult to determine its significance.
Nomenclature

On account of the comparatively long eclipse period, the time
taken to attain peak titers, and a marked tendency for the virus
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to remain cell-associated, the name "slowly cytopathic" or "slowly
growing" was suggested for EHV-2.*

In addition to the above

characteristics some "slowly cytopathic" equine herpesviruses that
were unrelated by cross-neutralization to the LK strain of EHV-2
were observed to exhibit a restricted

host range in vitro and

they also produced dense basophilic intranuclear inclusion bodies
as well as occasional basophilic intracytoplasmic inclusion
bodies.

For these reasons the name "equine cytomegalovirus" was

proposed for these viruses.
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Some investigators have questioned the classification of
EHV-2 isolates as members of a distinct cytomegalovirus-subgroup
of the herpesviruses.

Thus Plummer et al

87

concluded: "The

present criteria for regarding a virus as a cytomegalovirus are
exceedingly vague.

Until criteria which are a little more

definitive become available, we suggest that new herpesviruses not
be refe'rred to as cytomegaloviruses even it they do grow slowly in
tissue cultures."

During in vivo and in vitro studies of 6

strains of EHV-2, Harden et al

88

failed to find any evidence of

intranuclear inclusion bodies in the salivary glands of 30 horses
even though EHV-2 strains were isolated from 7 of them.

Also the

viruses were shown to have a wide host range in vitro and no
intracytoplasmic inclusions were observed in infected cells.
Furthermore, congenital infection of foals could not be produced
with the strains of EHV-2, and virus could not be isolated from
the urine of the 30 horses.

These results indicated that the

EHV-2 strains involved in the study did not share features
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commonly associated with herpesviruses classified as cytomegalo
viruses.

The investigators therefore suggested that the type 2

equine herpesviruses not be classified as cytomegaloviruses.
EHV-2 and Equine Disease
The significance of EHV-2 in the pathogenesis of equine
disease is not clear due to the frequent isolation of the virus
from both sick and apparently healthy horses.

However, evidence

has accumulated in recent years pointing to an etiological
relationship between EHV-2 infection and disease.
Initial infection with EHV-2 is believed to occur by
inhalation.^

The virus has been recovered from horses that showed

obvious signs of respiratory disease.*'

These included marked

enlargement of the regional lymph nodes and a profuse mucopurulent
nasal discharge resulting probably from secondary bacterial
complication.

In another report the virus was isolated from 12

foals and 2 adults of Arabian and other breeds with mild clinical
respiratory tract infection.
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Thein
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has recovered EHV-2 from

conjunctival swabs taken from adult horses and 4-week old suckling
foals with keratoconjunctivitis manifested as photophobia,
excessive lacrimation, and blepharospasm accompanied by pannus.
Blakeslee et al

91

provided some evidence associating

with respiratory tract infection of horses.

EHV-2

In their study two

6-week old foals (designated as horse 1 and horse 3 respectively),
and 3 adult horses were infected intranasally with 3x10^ TCID^ of
EHV-2, strain LK.

The 6-week old foals with relatively low levels
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of virus neutralizing and complement-fixing antibodies developed
coughs and serous nasal discharges within 21 days.

Laryngoscopic

examination revealed pharyngitis manifested as edema and hyperemia
of the dorsopharyngeal recess with lymphoid proliferation in the
pharyngeal walls.

The pharyngitis persisted for 232 days in one

foal (horse 1) and 98 days in the other (horse 3) with virus
recovered for 118 days in horse 1 and 98 days in horse 3.

None of

the three seropositive adult horses exhibited clinical signs of
disease although virus was recovered for 4 and 35 days in two of
the adults.
Results of the study above seem to indicate that EHV-2 is
capable of establishing an infection in horses and that young
foals may be more susceptible to infection than adults.

They also

support the concept of EHV-2 causing a persistent infection in
horses, as indicated by continued isolation of virus in the
presence of circulating antibodies.
In 1978 Palfi et al
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in Hungary reported on a series of

respiratory disease outbreaks in which losses due to EHV-2 were
recorded in 6 to 10 week old foals.

The outbreaks, which

prevailed for several months, had a morbidity of nearly 100% and a
mortality that ranged from 5% to 40% among the foals.

EHV-2 could

be isolated from the nasal discharge of acutely ill animals in
every case. Over 4-fold increases inneutralizing antibody could be
demonstrated against EHV-2 in acute and convalescent sera in all
cases.

However, no rise in antibody titer could be demonstrated

against EHV-1, equine influenza

or A^, parainfluenza-3, or
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against the soluble antigen of the first subgroup of bovine
adenoviruses.
The pathological features of the disease included catarrhal
pneumonia, lung abscess, and interstitial pneumonia with evidence
of secondary bacterial infection.

During one of the outbreaks,

Corynebacterium equi could be cultivated from lung lesions and
from the regional lymph nodes.

On the basis of the absence of

EHV-2 neutralizing antibody in the sera of acutely ill animals and'
the subsequent appearance of high titer antibody in their
convalescent sera, it was suggested that EHV-2 was the primary
causal agent of respiratory disease of the affected foals. There
was correlation of the clinical illness with loss of detectable
colostral antibody against EHV-2.
Despite reports of the pathogenic potential of EHV-2, the
pathogenesis of infection of horses with the virus remains to be
clearly defined.

Three factors may account for this observation:

1) little documentation of the pathogenic significance of EHV-2 is
available; 2) the lack of in vitro models for studying EHV-2
infections; and 3) the lack of animals unexposed to the virus,
thus making it difficult to do controlled or field trials with the
agent.
Experimental Host Systems
In an investigation of the characteristics of various strains
of EHV-1 and EHV-2 (including EHV-2 strain LK), Erasmus"^
inoculated the viruses intraperitoneally in newborn hamsters, and
intracerebrally in day-old mice.

He also applied the viruses to
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the scarified skin and cornea of rabbits.

Except for the EHV-1

strain, which produced fatal hepatitis in newborn hamsters, no
indication of infection was observed in any of the host systems
inoculated with the viruses.

In the same study, no pocks or other

signs of infection were observed in 10-day-old embryonated eggs
after infection with the viruses.

However, all the virus strains

produced CPE in primary and secondary cultures of fetal horse
kidney, lamb kidney and rabbit kidney cells, after varying periods
of incubation.

The CPE induced by EHV-1 appeared as early as 16

hours post infection (HPI) and was characterized by ballooning of
cells and their rapid detachment from the glass substrate.

The

CPE progressed very rapidly to complete cell destruction at 24
HPI.

With the EHV-2 strains, development of CPE was slow and the

time of appearance of CPE varied from 24 to 96 hours depending on
the cell type used.

For example, for EHV-2 LK strain grown in

fetal horse kidney, the time of appearance of CPE fell in the
range of 48 to 96 hours, and in rabbit kidney cells, the same
virus induced CPE formation in 24 to 72 hours.

In addition,

formation of large syncytia frequently occurred with the EHV-2 LK
strain, and Vero cells were found to be highly susceptible to the
virus.

It is interesting to note that while some EHV-2 strains

showed a high degree of cell association in fetal horse kidney
cells, the EHV-2 LK strain exhibited the least amount of cell
association.

More information is available on cell types from

various animal species that will support the growth of EHV-2
„

.

strains.

2,88
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About a decade ago, Harden et al

suggested that the use of

organ cultures among other techniques may help to elucidate
details of the pathogenesis and spread of EHV-2 infections.

To

date no studies have been undertaken in connection with light,
scanning and transmission electron microscopic examination of
EHV-2-infected organ cultures of equine respiratory (nasal,
pharyngeal and tracheal) epithelium.

Respiratory Tract Defense Mechanisms

The Mucociliary Clearance Mechanism
The patency and integrity of respiratory airways is
maintained by means of mucus secretion and its transport by
ciliary activity.
reviewed.
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The mucociliary clearance system was recently

Ciliated cells are distributed in patches in various

regions of the respiratory tract.

Intervening areas are composed

of goblet cells and undifferentiated columnar cells.

It was

observed that under normal conditions mucus was sparse and
discontinuous in the nasal, tracheal and bronchial airways.

The

cranial direction of ciliary beat and constant ciliary motility
were included in the criteria for normal ciliary activity.
As the mucus traps inhaled particles and ciliary movements
occur, the particles (eg. viruses and bacteria) are transported to
the pharyngeal region where they are swallowed.

Primary

malfunction of cilia has been emphasized as an important
pathogenetic step in the production of serious respiratory
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disease.
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A reduction in the movement of mucus either by

depression of ciliary activity or by an increase in mucus
secretion is likely to allow more time for virus to penetrate the
respiratory mucosa.
mucociliary

Virus particles that pass beyond the

system to the alveoli may encounter alveolar

macrophages and may be phagocytosed.

Role of Macrophages
Macrophages are an important component of host defense
against virus infections. They participate in many activities
including phagocytosis and killing of viruses, production of
interferon, destruction of virus-infected cells, and the
development of immune responses.
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Virus infection of macrophages

may result in death of the macrophages or may lead to a persistent
infection of the macrophages which may then aid in the spread of
the virus. •
Role of Secretory IgA
IgA is the chief immunoglobulin secreted on mucosal surfaces.
it exists in several different forms but that present in
secretions is composed of two four-chain units

plus a separate

glycoprotein, termed secretory piece, synthesized not by
lymphocytes but by epithelial cells.
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IgA produced by B

lymphocytes underlying the mucosal epithelium is selectively
transported across the epithelial cells into the mucus layer.
Antibodies of the IgA class predominate in nasal secretions and
they may neutralize a virus and prevent its attachment to
epithelial cells.

95

I

28

The Role of Interferon
The interferon system was reviewed recently.^ Many
interferons are soluble glycoproteins produced by stimulated cells
which, when released, are capable of protecting other cells
against virus infection.

Interferon appears earlier than humoral

and cell mediated immune responses and it is operative within
hours of infection.
Interferon does not directly inactivate virus.

Instead, it

acts by reacting with membranes of cells surrounding the producer
cells to derepress genes which code for antiviral effector
molecules that inhibit viral protein synthesis.

Viral protein

synthesis may be inhibited by changes affecting initiation of
protein synthesis, polypeptide elongation, and function of viral
mRNA.

These changes may be mediated directly or indirectly by

interferon effects on induction of protein kinases, depletion of
specific tRNAs, activation of an endonuclease, methylation changes
in viral RNA, and a general alteration of cellular RNAs.
The role of interferon in recovery from viral infectons
depends mainly upon two factors, namely, the effectiveness of the
virus as a stimulator of interferon production, and the
susceptibility of the virus to the antiviral action of interferon.
Most respiratory tract viruses are believed to be highly sensitive
to interferon.
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Effect of Virus on Cytoskeletal Elements

Three chemically distinct filamentous systems constitute the
cytoskeleton of vertebrate cells: microfilaments, intermediate
filaments, and microtubules.
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The filaments of each system have

characteristic diameters: microfilaments (5-7nm), microtubules
go

(20-25nm), and intermediate or lOnm filaments (8-12nm).

The

interactions of these systems with one another appear to be
essential for several cellular functions including maintenance of
cell shape, intracellular transport, motility, and adhesion.
Microfilaments are structures found in nonmuscle cells that
perform many functions related to cell motility.

They are also

involved in the three-dimensional organization of the
cytoskeleton.
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The term microfilament is now reserved for

actin-containing filaments with a diameter of about 7nm.
Recently, a microfilament-associated protein, called fimbrin, was
demonstrated to crosslink filamentous actin (F-actin) in vitro to
form bundles of filaments.
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The possibility of involvement of

this phenomenon in polymerization and depolymerization of
transient structures known to contain fimbrin, such as membrane
ruffles and microvilli, was considered.
The intermediate-sized filaments are the least understood of
the three filamentous systems.

They form an interconnecting

network and provide what appears to be a cytoskeletal frame-

.

work.
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Microtubules are the collective name given to subcellular
components whose basic subunit is t u b u l i n . M i c r o t u b u l e s are

i
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ubiquitous in eukaryotic cells where they may be involved in such
diverse functions as changes in cell shape,
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cell surface

receptor mo bi l it y, s ec re ti on of h o r m o n e s , a n d mitosis.
Microtubules are present in centrioles,

and they have also been

found in motile cellular appendages such as cilia and
flagella.*^’* ^

Biochemical studies indicate that colchicine,

vinblastine, and related drugs interfere with microtubule
polymerization due to their ability to bind the tubulin
subunit.
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These drugs have been used to demonstrate the

involvement of microtubules in the cellular activities mentioned
above.
Pathological changes in many viral diseases are reflected in
morphological alterations of cells.

An investigation of the

mechanisms by which viruses cause cytopathic effects associated
with cell morphology changes will provide insight into the
pathogenesis of viral diseases.
One method for studying cytoskeletal changes in cells is the
microtubule paracrystal (PC) assay.

The basis for the microtubule

PC assay is that treatment of cultured cells with vinblastine
sulfate results in the formation of large microtubule paracrystals
which are easily detected under the phase contrast
microscope.

The technique was used by Ebina et al* ^ to

investigate the role of microtubules in cytopathic changes induced
by animal viruses.

Data from the investigation indicated that the

appearance of CPE in adeno-and herpesvirus-infected HeLa cells was
correlated with a molecular alteration of microtubules detectable

31

by the inhibition of PC formation.

Another method is the indirect

immunofluorescence technique which has been used extensively to
detect morphological alterations of cytoskeletal
components.^*98,

a<jvant;ages of the immunofluores

cence method was discussed in relation to cytoplasmic microtubules
in normal and transformed cells in culture.
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The procedure is

simple, and it permits immediate resolution of microtubules in
cultured mammalian cells.

The images produced by the technique

correlate closely with transmission electron microscopic images of
cytoplasmic microtubules.

Immunofluorescence studies have shown

that canine distemper virus causes a total reorganization of all
the cytoskeletal structures with the most notable changes in the
microtubules and intermediate filaments.
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In the work that follows, the biological and pathogenic
properties of EHV-2 were assessed in various experimental host
systems including cell cultures (equine and continuous cell
lines), and equine respiratory organ cultures (fetal and adult origin).
EHV-1 provided a comparative model for EHV-2 infections in the
study.

The following investigations were made:

1) virus growth

in cell and organ cultures, 2) effect of virus infection on
ciliary activity of organ cultures and on cell monolayers, 3)
virus morphogenesis in organ cultures, 4) effect of virus
infection on surface morphology of organ cultures, and 5) effect
of virus infection on the cytoskeleton.
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CHAPTER 1

EQUINE HERPESVIRUSES TYPE 1 AND 2:

GROWTH AND

CYTOPATHIC EXPRESSION IN CELL AND ORGAN CULTURES
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SUMMARY
The pathogenicity of equine herpesvirus type 1 (EHV-1) and
type 2 (EHV-2) were assessed and compared in monolayer cultures
of equine and continuous cell lines and in equine respiratory
organ cultures.

The equine cell lines included fetal donkey

alveolar macrophages(FDAM) and fetal equine (pony) kidney
(FEK), and the continuous cell lines included rabbit kidney
(LLC-RK^) and african green monkey kidney (VERO).

Organ

cultures were derived from respiratory tissues (nasal, tracheal
and pharyngeal mucosae) of seronegative donkey (F1D1) and pony
(F1M1) fetuses,and of a seropositive adult pony (Al).
Pathogenicity

of EHV-1 and EHV-2 was demonstrated in the cell

and organ cultures, and EHV-1 was observed to be more
pathogenic than EHV-2.
In cell cultures, EHV-1 multiplied and produced cytopathic
effects (CPE) as early as 6 hours post inoculation (HPI) in
LLC-RK^ cells.

The CPE induced by EHV-I was characterized

mainly by cell rounding and lysis.

EHV-2 multiplied more

slowly and produced CPE as early as 48 HPI in LLC-RK^, FDAM,
and FEK cells which consisted mainly of rounding of cells and
syncytia formation.
In organ cultures, EHV-1 multiplied more rapidly and to
higher peak titers than EHV-2.

Growth of EHV-2 was inhibited

in Al nasal cultures but not in the F1M1 and F1D1 nasal cul
tures in which infectious virus was recovered for at least 14
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days in F1M1 cultures, and at least 30 days in F1D1 cultures.
Multiplication of EHV-2 was restricted in pharyngeal cultures.
Infectious EHV-2 could not be detected in pharyngeal culture
fluids after 5 days post inoculation (DPI).

Ciliary activity

in tracheal and nasal cultures terminated earlier in EHV-1 and
EHV-2 infected cultures than in uninfected cultures.

The time

interval from attainment of peak virus titer to cessation of
ciliary activity ranged from 0 (simultaneous occurrence) to 6
days for EHV-1 and 3 to 27 days for EHV-2.
significance of the results is discussed.

The in vivo

*

INTRODUCTION
Equine herpesvirus type 1 (EHV-1) and type 2 (EHV-2) have
been implicated in acute respiratory tract disease in horses
during their first two years of life.

1-3

In addition, EHV-1

may cause abortion and nervous syndromes in pregnant mares.
Serologic data indicate that both viruses are widespread among
2 6

horse populations. ’

The pathogenesis of equine herpesvirus

(EHV) induced respiratory disease is poorly understood. One
reason for our poor understanding is that most horses have been
naturally exposed and only few seronegative horses are
available for experimental studies.
Organ and cell cultures have been used for the study of
virus-cell interactions.

7-9

Infection patterns in organ

cultures especially may mimic those in whole animals, as
demonstrated in the replication of infectious bovine
rhinotracheitis virus in different bovine tissues,^ and
influenza virus in different ferret tissues.

11 12
*

The combined

use of organ and cell culture techniques may help to elucidate
details of the pathogenic mechanisms operative in equine
herpesvirus respiratory

infections.

The purpose of the present study was to investigate the
pathogenicity of EHV-1 and EHV-2 in vitro using a variety of
cell lines and organ cultures derived from equine respiratory
tissues.
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MATERIALS AND METHODS
Virus
EHV-1(strain KyD) and EHV-2 (strain LK) were obtained from
Dr. J.E. Pearson, National Animal Disease Center, Ames, Iowa.
Stock suspensions of EHV-1 and EHV-2 were prepared by 1 and 2
passages in monolayer cultures of either rabbit kidney
(LLC-RK^) in the 257th to 258th subpassages, or fetal equine
kidney (FEK) in the 2nd to 4th subpassages.

The viral prepa

rations were stored at less than -60 C until used.
Cell cultures
Rabbit kidney epithelial cell line LLC-RK^(ATCC it
CCL106/S921, passage 253) and the the VERO line of african
green monkey kidney

cells (ATCC it CCL81/S1415, passage 251)

were obtained from the Cell Culture Center at the School of
Veterinary Medicine, Louisiana State University, Baton Rouge.
Primary cell cultures of fetal equine kidney (FEK) were
prepared by standard methods, using a growth medium consisting
of Eagle's minimal essential medium (MEM) supplemented with 10%
fetal bovine serum (FBS), 100 IU of potassium penicillin G and
100 meg of streptomycin sulfate/ml.

The medium was buffered to

a final concentration of lOmM NaHCO^ and 25mM HEPES
(N-2-hydroxyethyl piperazine-N-2-ethanesulfonic acid).
cells were used in the 2nd to 7th subpassages.
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The FEK
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Donkey alveolar macrophage (FDAM) cultures were initiated
from a near-term donkey fetus.

The fetus (F1D1) was delivered

by Caesarean section and was immediately exsanguinated after
collection of blood (by jugular venipuncture) for serology.
Blood was also collected from the dam (Dl) for a similar
purpose. The lungs with a piece of trachea (approximately 3
inches in length) attached were removed and aseptically
transported to a vertical laminar flow hood (Nuaire, Inc,
Plymouth, Mn.) where bronchopulmonary lavage was performed.
The constituents of the lavage fluid were as described
previously 13

with minor modifications.

The fluid contained

0.15M saline, 5mM glucose, 2mM EDTA, 25mM HEPES
buffer, pH 7.2, 5 meg of amphotericin B per ml, 200 IU of
potassium penicillin G per ml, and 200 meg of streptomycin
sulfate per ml.

The trachea was clamped close to its point of

bifurcation, and using a 50 ml syringe and 18 gauge needle,
lavage fluid was introduced into the lungs which were then
gently massaged.

The fluid was then collected by suction into

a 50ml syringe.

Washing of the lungs required a total of 100ml

of lavage fluid and about one-half of this could be recovered.
The washings were centrifuged at 300g for 10 minutes in a
Beckman centrifuge (Beckman, Spinco division, Palo Alto,
California). The pellets were resuspended and pooled in a
growth medium (described above). The cells were counted in a
hemocytometer chamber and the suspension was diluted to give
0.5 to 1.0 x 10^ cells/well. The suspension was added to 6-well
cluster plates (Flow Laboratories, Inc., Hamden, Connecticut)
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so that there were about 0.5 to 1.0 x 10^ cells/well.
The cultures were incubated for 3 h at 37C in a humidified
atmosphere containing 5% CX^.

At this time, they were washed

twice with MEM to remove nonadherent cells, and reincubated. In
14 to 25 days, dense isolated colonies appeared in the cultures
which could readily be subcultured, using standard procedures,
to form monolayers of epithelial type cells.

The cells were

judged to be alveolar macrophages on the basis of the presence
of esterases as demonstrated by staining with alpha-naphthyl
acetate.

14

Their plastic adherence properties and morphology

as determined by phase-contrast examination

(cytoplasmic

spreading, accumulation of refractile vacuoles and vesicles,
and short cytoplasmic extensions with enlarged blunt ends) and
their subsequent survival in culture for over 60 days (without
subculturing) were additional evidence.^

The alveolar

macrophages were used in the 7th subpassage.
Organ Cultures
Relevant portions of the respiratory tract were obtained
from near-term donkey (F1D1) and pony (F1M1) fetuses and from a
6-year old apparently healthy adult pony (Al). Serum was
harvested from jugular blood of these donors and tested in
neutralization tests.

Nasal and tracheal organ cultures were

prepared according to methods previously described by O'Niell
and Issel.

16

Two nasal fragments, each approximately 0.7 cm x

0.7 cm, were planted with their epithelial surfaces up in each
60 mm plastic tissue culture dish (Falcon Labware Division,
Oxnard, California).

Tracheal rings were placed in 60 mm
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plastic tissue culture dishes, one or two rings per dish,
depending on size.

For the pharyngeal cultures, mucosal

sections (approximately 1.5 xl.5 cm) were removed aseptically
from the pharynx of a pony fetus.

The sections were rinsed 3

times in MEM supplemented with 200 IU of potassium penicillin G
per ml, 200 meg of streptomycin sulfate per ml, 5 meg of
amphotericin B per ml, and planted, 2 per dish, in 60 mm
plastic tissue culture dishes.
Organ cultures in each dish were maintained in 3 ml of
Leibovitz's L-15 medium (Gibco, Grand Island NY) at 37 C in a
humidified chamber.

Tracheal and pharyngeal cultures were

rotated at 100 rpm on a gyrorotary platform (Labline
Instruments, Inc., Melrose Park, 111).

Viability of the nasal

and tracheal cultures was assessed by observing ciliary
motility with an inverted microscope.

After 24 or 48

hours, cultures with immotile cilia were discarded and the rest
were used for virus growth studies.
Virus titration
Infectivity titrations were performed in FEK cell
monolayers in microtiter plates.

Ten-fold dilutions of virus

were made in MEM containing antibiotics, and 0.025 ml of each
dilution was placed in replicate wells of 96-well microtiter
plates (Costar, Cambridge, MA).
of MEM.

Control wells received 0.025ml

FEK cell monolayers in 75-cm

2

(surface area) flasks

were trypsinized using versene (EDTA) trypsin (0.8% NaCl, 0.04%
KCL, 0.1% dextrose, 0.058% NaHC03> 0.02% EDTA, and 0.25%
trypsin) and resuspended in growth medium to a concentration of
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1.0 x 10^ cells/ml.

To each well of the microtiter plates

0.05ml of the cell suspension was added and the plates were
incubated at 37 C for 6 days.

The plates were examined daily

with an inverted microscope and scored on the basis of viral
cytopathic effects (CPE). The 50% endpoint was determined by
the Reed-Muench method.^
Neutralization Test
A microneutralization test was performed on serum samples
collected from donor animals as described.
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Serum was heat

inactivated (56 C for 30 min) and stored at -20 C until used in
the serum neutralization (SN) test.

The SN test was performed

in FEK cells in 96-well microtiter plates (Costar, Cambridge,
MA).

Serum dilutions of 1:2 to 1:64 were made in two-fold

steps, with each dilution being tested in duplicate wells.
Virus neutralizing titers were expressed as reciprocal of the
final serum dilution that completely inhibited CPE with 100-250
TCID^q of virus.

Endpoints were determined 7 days after

inoculation.
Virus growth in cell cultures
Monolayers of FEK(12 x 10^ cells), FDAM (2 x 10^ cells)
VERO (12 x 106 cells) and LLC-RK1 (8 x 106 cells) in 25cm2
flasks, (Costar, Cambridge, MA)

were inoculated with EHV-1 and

EHV-2 at a multiplicity of infection (MOI) of 10, except for
VERO cells which were inoculated with EHV-1 at MOI of 6.6.

At

various intervals, culture fluids were harvested and stored at
less than -60 C until titrated for extracellular virus.
Cultures were also examined daily for CPE which were scored as
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follows: 0= Normal cell morphology was observed, +_ = Less than
25% of the monolayer exhibited CPE, + = 25% to 50% of the
monolayer exhibited CPE, ++ = 50% to 75% of the monolayer
exhibited CPE, +++ = 75% to 95% of the monolayer exhibited CPE
++++ = over 95% of the monolayer exhibited CPE.
Virus growth in organ cultures
Prior to virus inoculation, organ cultures were maintained
for 24 to 48 hours after initiation.

Medium was removed from

culture dishes and cultures were inoculated by dropping 0.5 ml
of virus suspension on the epithelial surface of the principal
tissue fragments; inocula of approximately 8 x 10^ TCID^q of
EHV-1 or approximately 4 x 10^ TCID^q of EHV-2 were added to
each dish.

Virus was allowed to adsorb for 1 h after which

time infected cultures were washed 3 times in phosphate
buffered saline (PBS).

This was followed by the addition of 3

ml per dish of Leibovitz's L-15 medium.

The medium was changed

daily after harvesting aliquots for titration from infected and
uninfected cultures.
until used.

Samples were stored at less than -60 C

Growth kinetic studies were made on pools of

medium obtained from groups of 3 or 4 dishes.
Ciliary activity of infected and uninfected nasal and
tracheal organ cultures was monitored daily using an inverted
microscope.

Ciliary activity was scored on an all or none

basis, i.e., if any ciliary movement was noted it was recorded
as positive.

RESULTS
Virus growth in cell cultures

(i) Growth Kinetics.

To determine loss of infectivity experienced during the
period of incubation used for the cell and organ cultures,
aliquots of stock virus in medium with 10% FBS were incubated
at 37C for 4 to 8 days.

At daily intervals, samples were

removed, frozen and stored at less than -60C until infectivity
titrations were made in FEK cell monolayers in microtiter
plates.

After 24 hours of incubation at 37C, loss of

infectivity equivalent to 75% for EHV-1 and 84% for EHV-2 was
observed (Table 1).

By 4 days, 97% of infectivity of both

EHV-1 and EHV-2 was lost, and by 8 days, only 0.8% of original
infectivity of EHV-2 remained.
Growth of EHV-1 and EHV-2 occurred in FEK, FDAM, VERO, and
LLC-RK^ cells, with EHV-1 multiplying to a peak titer earlier
but attaining a lower peak titer than EHV-2 in all the cell
cultures (Tables 2 and 3).
(ii) Cytopathic effects.
In EHV-1 infected cultures (Table 2), CPE were observed as
early as 6 hours post inoculation (HPI) in LLC-RK^ monolayers,
and at 24 HPI over 95% of the monolayer was involved.
the monolayer became rounded and swollen.

Cells in

At 96 HPI the

degenerate and fragile cell sheet detached from the flask.

CPE

were evident at 12 HPI in FEK and FDAM cultures and progressed
faster in FEK than in FDAM cells.

At 24 HPI, CPE in FEK cells

were characterized by vacuolation and lysis of cells.
HPI over 90% of the cells forming the monolayer had
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By 72
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degenerated.

In EHV-1 infected FDAM cultures, CPE at 24 HPI

consisted of few rounded, refractile cells.

By 48 HPI many

rounded and vacuolated refractile cells were present in the
monolayer.

CPE in EHV-1 infected VERO cultures were delayed

until 48 HPI (Table 2).

Between 48 and 96 HPI, CPE progressed

from ++ to ++++ and refractile rounded cells predominated.
In EHV-2 infected cultures (Table 3), CPE appeared as
early as 48 HPI in FEK, FDAM, and LLC-RK^ cells, and as late as
72 HPI in VERO cells, and consisted of cell rounding, breaks in
continuity of monolayers, and syncytia formation.
Immune status determination
Serum samples from the fetuses were negative for
neutralizing antibodies to EHV-1 and/or EHV-2, whereas those
from their dams were antibody-positive for the two viruses
(Table 4).

Virus growth in organ cultures
Growth kinetics of EHV-I and EHV-2 in equine respiratory
organ cultures are presented (Tables 5-9).

Virus growth

occurred in all cultures except F1M1 pharyngeal (Table 8) and
A1 nasal (Table 9) cultures.

Infectious virus was recovered up

to 10 (EHV-1) and 30(EHV-2) days post inoculation (DPI) from
infected F1D1 cultures (Tables 5 and 7).

In F1D1 cultures

EHV-1 multiplied to a 10-fold higher peak titer than EHV-2
(Figs 1 and 2) but titers of EHV-1 declined steadily after
reaching,peak values while thoseof EHV-2 reflected a steady
state infection (Figs 3 and 4).
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Ciliary activity of uninfected (control) and virus
infected equine respiratory organ cultures are shown (Tables
10-14).

The time interval from attainment of peak virus titer

to cessation of ciliary activity ranged from 0 (simultaneous
occurrence) to 6 days for EHV-1, and 3 to 27 days for EHV-2.
Ciliary activity of all tissue sections ceased as early as 2
DPI (EHV-1 infected A1 nasal, Table 11), 6 DPI (EHV-2 infected
F1D1 tracheal, Table 12), 10 DPI (control F1D1 tracheal, Table
12), and as late as 8 DPI (EHV-1 infected F1D1 nasal, Table
10), 31 DPI (EHV-2 infected F1D1 nasal, Table 12), over 38 DPI
(control F1D1 nasal, not shown).

In A1 cultures, ciliary

movements stopped at about the same time in EHV-2 infected
nasal and tracheal cultures (7 and 8 DPI, respectively, Table
13).

In general, ciliary movements were abolished earlier in

cultures infected with EHV-1, as indicated by data from F1D1
studies (Table 14).

DISCUSSION

Results of the present study indicate that EHV-1 and EHV-2
are potentially pathogenic as determined by their ability to
grow and cause CPE in monolayer cultures of equine alveolar
macrophages as well as cause earlier cessation of ciliary
activity in infected than in uninfected equine respiratory
organ cultures.

EHV-1 grew more rapidly and was more

cytopathic than EHV-2.
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The CPE caused by EHV-1 occurred early and were
characterized by cell rounding and lysis, whereas EHV-2 CPE
developed late and they consisted of rounding of cells and
syncytia formation.
19

Erasmus.

Similar findings have been described by

Our present findings support the concept of EHV-2

having a prolonged growth cycle and delayed CPE in cultured
cells.20
Alveolar macrophages supported the growth of EHV-1 and
EHV-2.

Peak virus titers in FDAM were relatively low when

compared with those in FEK cells.

Forman et al 13 also observed

this difference in virus yields in relation to the replication
of IBR virus in cultured bovine alveolar macrophages (AM) and
Madin-Darby bovine kidney (MDBK) cells.

Relatively low yields

of infectious IBR virus was attained in AM as compared with
high yields in MDBK cells.

Since cell cultures in the above

studies were inoculated at an input multiplicity of infection
of 10, it is possible that the low yields in the macrophage
cultures were due to the production of low quantities of
infectious virus on a per-cell basis.
Even though EHV-1 and EHV-2 attained lower titers in FDAM
than in FEK cells, CPE became manifest at the same time in the
two cell types suggesting that CPE may develop without release
of large numbers of infectious virus.

The replication of EHV-1

and EHV-2 in cultured FDAM with subsequent production of CPE
may have significant implications in the pathogenesis of equine
respiratory disease as the alveolar macrophage functions as the
primary defense against inhaled particulate matter.

21

Virus
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infection of the lung may impair the microbicidal function of
alveolar macrophages as well as expose bacterium-specific
receptors on- lung tissue.

These processes may promote

bacterial adherence to pulmonary tissue and lead eventually to
severe bacterial pneumonia. Thus Palfi et al

3

isolated

Corynebacterium equi from the lungs of foals that died from
EHV-2 respiratory illness.

Studdert
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has also reported

involvement of streptococci of Lancefield's Group C in acute
EHV-1 respiratory disease.
In infected LLC-RK^ cells, sharp decreases in EHV-1 titer
correlated well with rapid production of CPE in contrast to the
small decreases in EHV-1 titer in thermal decay studies.

This

difference reflects the detachment of virus infected cells and
their subsequent loss during the washings and media
replenishment.
Although biological properties such as virus growth and
CPE may be studied in cell cultures, it may be noted that
infection patterns in dedifferentiated cells may not represent
the situation in vivo.

Therefore in pathogenicity studies, it

may prove more useful to couple short-term cell culture studies
with organ culture or whole animal studies.
Equine nasal and tracheal organ cultures supported the
growth of EHV-1 and EHV-2 except that EHV-2 growth was
inhibited in nasal cultures derived from a seropositive adult
pony.

Probably the high levels of serum neutralizing antibody

to EHV-2 (titer 1:64 or over) in the donor pony was associated
with high titers of residual anti-EHV-2 IgA that may have
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neutralized EHV-2 and prevented its multiplication in the nasal
cultures.

In contrast, low levels of anti-EHV-1 neutralizing

antibody (titer 1:4) reflected in low titers of residual
anti-EHV-1 IgA could have allowed EHV-1 to multiply in the
nasal cultures. By comparison, EHV-1 grew more rapidly in the
organ cultures during the first 24 to 48 hours and reached much
higher peak titers than EHV-2.
It is noteworthy that in the cell culture studies peak
titers of EHV-1 were lower than those of EHV-2.

Also, EHV-1

and EHV-2 were released to higher peak concentrations in cell
cultures than in organ cultures, suggesting that infections in
cell cultures may differ from those in organ cultures which
consist of fully differentiated cells that may vary widely in
their susceptibility to a virus.

Although immune and

inflammatory responses may be largely absent in organ cultures,
previous work indicates that infection patterns in these
cultures closely approximate in the vivo situation.^ ^
Blakeslee et al
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cited from Harden and co-workers that

pharyngeal lymphoid follicles might be the initial site of
EHV-2 replication with subsequent transmission to other
organs via mononuclear cells (probably monocytes) of the blood.
On the basis of this assumption, our present findings in
pharyngeal cultures are somewhat unexpected as EHV-2 titers
were much lower when compared with the high titers in nasal
cultures. In addition, infectious EHV-2 was not detected in
pharyngeal culture fluids after 4 DPI.
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Previous reports indicate that organ cultures from
different anatomic regions of the respiratory tract may differ
in their ability to support virus growth.

Shroyer et a l ^

found that IBR virus was released more readily from infected
fetal bovine tracheal epithelium than
epithelium.

from infected nasal

O'Niell et a l ^ reported that equine influenza

virus-A^ grew better in fetal equine nasal epithelium than in
tracheal epithelium.

In the present study, EHV-1 grew slightly

better in fet^l and adult equine tracheal cultures than in
nasal cultures.
Two factors may account for the above difference in
susceptibilities of nasal and tracheal tissues, namely, the
presence of virus-specific receptors on epithelial cells and
the immunologic competence of the organ concerned.
Virus-specific receptors may mediate virus attachment to cells
and thus facilitate virus multiplication.

Differences in the

number of cells with virus-specific receptors in tracheal and
nasal epithelia may be responsible for the differential
susceptibilities of these tissues. It has been reported that
the number of ciliated cells in mammalian airways decreases
toward the smaller airways.
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Thus different regions of the

respiratory tract may show different susceptibilities to virus
infection if the infection depends on the presence of ciliated
cells.
A variation in immunologic competence is thought to exist
for different regions of the respiratory tract.

Wilkie

25

reported that within the respiratory tract secretions, IgG and

IgA predominate, but the ratio of IgA to IgG varies so that IgA
predominates in the nose whereas the quantity of IgG increases
in tracheal secretions.

Antibodies of the IgA and IgG classes

may neutralize virus and prevent virus infection of epithelial
cells of the respiratory tract.

The relative amounts of these

immunoglobulins in local secretion at the time of virus
exposure may determine the outcome of infection.

Future

experiments with respiratory organ cultures should test for the
presence of virus-specific antibodies in nasal and tracheal
secretions prior to harvesting the tissues for virus
inoculation studies. It has been reported that beyond 6 months
of gestation, the equine fetus acquires increasing ability to
produce immune responses.
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The significance of these responses

in determining the relative susceptibility of tracheal and
nasal mucosae to virus infection may require further investiga
tion.
Burrows and Goodridge

26

have observed that ponies with

serum neutralizing (SN) antibody titer greater than 1:24 are
resistant to experimental intranasal EHV-1 challenge.

Findings

from our studies appear to reflect this view. Nasal organ
cultures made from tissues of a pony adult (Al) that had SN
antibody titer of 1:4 were found to be susceptible to EHV-1
infection.
Our present results and in vivo observations of other
workers appear to indicate that a certain minimum level of SN
antibody would also protect members of the equine species
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against intranasal EHV-2 challenge.

Nasal organ cultures

derived from pony (F1M1) and donkey (F1D1) fetuses each of
which had no detectable SN antibody supported the growth of
EHV-2 , but similar cultures derived from an adult pony (Al)
having SN antibody titer greater than 1:64 and probably having
residual mucosal IgA antibody were non permissive for EHV-2.
Organ culture results, however, have to be interpreted with
caution as important differences exist between organ cultures
and the parent tissue in vivo. Environmental factors such as
immune responses, microbial flora, cooler temperature of nasal
tissue, and inhibitory substances in mucosal secretions may be
present in vivo but absent in organ cultures.

It is therefore

possible that organ culture findings may not represent what
actually occurs in the intact animal.

Nevertheless, organ

cultures may mimic the in vivo situation more closely than cell
cultures.
Blakeslee et al

23

infected 3 adult horses and two 6 week

old foals intranasally with 3.0 x 10^ TCID,.^ of EHV-2 strain
LK.

Prior to their experiment, SN antibody was demonstrated in

the adults.

One of the foals had low levels of SN antibody

(titer 1:2) and the other had none detectable.

Both foals

developed a chronic pharyngitis whereas this lesion was not
observed in the adults.

Passive immunity in the foals and

active immunity in the adults may have protected the animals
from developing an acute respiratory tract disease. Palfi et al
3

did not detect SN antibody in 6 to 10 week old foals that had

acute EHV-2 respiratory disease.

Further investigation is
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needed in regard to the role of serum neutralizing antibody
levels in protection of horses against EHV-2 infections.

The

significance of nasal mucosal resistance should not be totally
excluded as the upper respiratory tract is the portal of entry
for most respiratory viruses.

The possibility of age-dependent

resistance to infection with EHV-2 also requires investigation
as the above observations suggest that young animals may be
more susceptible than older ones to EHV-2 infection. Losses due
to EHV-2 may, however, decrease among young stock having
antibody passively derived from the dam. Finally, the
phenomenon of viral interference (mediated probably via
interferon production by previously infected nasal epithelial
cells) may have contributed to failure of EHV-2 multiplication
in Al nasal cultures, as an uncharacterized cytopathic agent
was isolated from culture fluids of uninoculated Al nasal and
tracheal cultures (data not shown).
Our results appear to support an in vivo observation of
Henning
EHV-1.
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that horses may be more susceptible than donkeys to

EHV-1 reached a ten-fold higher peak concentration in

pony adult than in donkey fetal cultures.

An epidemiologic

implication of findings in these studies is that donkeys as
members of the Family Equidae, could act as carriers for EHV-1.
Our findings suggest that donkeys may also be less susceptible
than ponies to EHV-2 infection as the virus multiplied to a
ten-fold higher peak titer in pony than in donkey fetal nasal
cultures.

However, in fetal tracheal cultures, EHV-2 titers

remained constant for at least 5 days in donkey cultures but
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showed an inconsistent pattern in pony cultures during the same
period.
An interesting finding of this study was the consistent
isolation of EHV-2 from susceptible nasal organ cultures for at
least 31 days and at least 14 days in infected donkey and
pony fetal nasal cultures respectively.

The finding agrees

with the observation of previous investigators that EHV-2
causes a persistent infection of horses.

After intranasal

inoculation of two 6-week old foals with EHV-2, Blakeslee et al
23

consistently isolated the virus for 118 days from one foal

and 98 days from the other.

Other workers have recovered EHV-2

from the nasal cavity of experimentally infected horses for 418
days.
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One must assume that the EHV-2 infected horse may shed

EHV-2 for an indefinite period of time.

The frequent

isolations of EHV-2 strains from buffy coat cells suggest that
EHV-2 latency may be maintained in these cells which may also
serve to spread the virus to other sites of the body such as
the testicle, genital tract, spleen, and kidney.

6 22

’

These in

vivo observations are in marked contrast to the failure to
isolate EHV-1 for longer than 14 days after primary
infection.
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Further work concerning the treatment of virus

inoculated organ cultures with specific antibody would provide
additional information on EHV-2 persistence. Persistence of
infection in the presence of antibody would imply intracellular
survival and/or intercellular spread of EHV-2 both of which may
help in counteracting host immune defenses.
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Ciliary activity in tracheal and nasal cultures terminated
earlier in infected cultures than in uninfected cultures and a
variation in the time interval from attainment of peak titer to
cessation of ciliary activity in all cultures was observed for
EHV-1 and EHV-2.

For EHV-1, the interval ranged from 0 to 6

days whereas for EHV-2, the interval ranged from 3 to 27 days.
These results and the other accumulated data suggest EHV-1 to
be more pathogenic than EHV-2.

The suggestion is supported by

the ability of EHV-1 strains to cause abortions and acute
respiratory disease while EHV-2 strains cause subclinical
infections and only occasional severe respiratory disease after
13

22

natural exposure. ’ ’

The present results suggest that

combined use of cell and organ culture models can provide
useful information on pathogenic mechanisms of viral infections
of the respiratory tract.
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Table 1 - Thermal decay of EHV-2 and EHV-1 in cell-free medium*
containing 10% fetal bovine serum at 37C____________

Titer of virus (Log^O TCID5 O/O.025ml) on given
day after incubation at 37C__________________
Virus

0

1

2

3

4

6

8

EHV-2

6 .2#

5.4

5.4

4.8

4.6

4.6

4.1

EHV-1

6.3

5.7

5.5

5.2

4.7

ND

ND

*

Minimum essential medium (Eagle), with hepes (25mM), pencillin G
(100 IU/tnl), and streptomycin (lOOmcg/ml).

#

Virus titer prior to incubation. Virus titration was made in fetal
equine kidney (FEK) monolayers in microtiter plates.

ND = Not determined.

Table 2 - Growth kinetics of EHV-1 in equine and continuous cell lines*

Extracellular virus titer^/CPE**on given times after inoculation
Cell type##

1.5h

6h

12h

24h

FEK

2.5/0

2.7/0

6.0/+

6.5/+

FDAM

1.3/0

1.7/0

3.2/+

VERO

2 .0/0

3.0/0

LLC-RKj

2.2/0

2.0/+

48h

72h

96h

6.0/++++

5.5/++++

4.8/++++

3.5/++++

5.0/+

4.2/++

4.0/+++

3.0/++++

2.3/++++

3.2/0

4.0/0

5.0/++

5.3/+++

5.0/++++

4.7/++++

4.7/++

5.7/++++

5. 0/++++

3.0/++++

1.8/NA

0/NA

120h

*

Cell monolayers were inoculated with virus at a multiplicity of infection (MOI) of 10 (except for
Vero. cells which was 6 .6).

#

Expressed as log^o TCID50/O.025 ml; virus titration was made in FEK monolayers in
microtiter plates.

**

Rated as follows: 0 = No CPE, _+ = less than 25% of monolayer exhibited CPE, + = 25%-50% of
monolayer exhibited CPE, ++ = 50%-75% of monolayer exhibited CPE, +++ = 75%-95% of monolayer
exhibited CPE, ++++ = >95 of monolayer exhibited CPE.

##

Equine cell lines:

FEK = fetal equine kidney, FDAM = fetal donkey alveolar macrophage.

Continuous cell lines:
kidney.

VERO = african green monkey kidney, LLC-RKj = New Zealand white rabbit

NA = Not applicable; all cells detached from the flask surface.

Table 3 - Growth kinetics of EHV-2 in equine and continuous cell lines*
Extracellular virus titer^/CPE**on given times after inoculation
Cell type##

6h_______ 12h______ 24h______ 48h______ 72h_______ 96h_______ 120h______ 144h

FEK

2.7/0

1.0/0

3.7/0

6.0/+

7.0/+

5.7/++

4.7/++++

4.5/++++

FDAM

1.5/0

0.7/0

3.5/0

5.0/+

5.0/+

5.7/++

4.7/++++

3.7/++++

VERO

2.7/0

0/0

2.2/0

3.5/0

4.7/+

5.5/jf

5.5/+

4.7/++

LLC-RKi

2.5/0

0.7/0

4.5/0

5.3/++

6.0/++++

5.0/++++

4.7/NA

3.5/NA

*

Cell monolayers were inoculated with virus at a multiplicity of infection (MOI) of 10.

#

Expressed as log^Q TCID^q/0.025 ml; virus titration was made in FEK monolayers in microtiter
plates.

**

Rated as follows:

0 = No CPE, +_ = less than 25% of monolayer exhibited CPE, + = 25%-50% of

monolayer exhibited CPE, ++ - 5G%-75% of monolayer exhibited CPE, +++ = 75%-95% of monolayer
exhibited CPE, ++++ = >95 of monolayer exhibited CPE.
##

Equine cell lines:

FEK = fetal equine kidney, FDAM = fetal donkey alveolar macrophage.

Continuous cell lines:

VERO = african green monkey kidney, LLC-RK^ = New Zealand white

rabbit kidney.
NA = Not applicable; all cells detached from the flask surface.
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Table 4 - Neutralizing antibody titer to EHV-2 and EHV-1 in sera of
experimental animals

Titer*
Animal

Pony fetus (FlMl)
Dam (Ml)
Pony adult (Al)
Donkey fetus (F1D1)
Dam (Dl)

*

EHV-2

<2

EHV-1

32

ND
ND

>_64

4

<2
2

<2

4

Expressed as reciprocal of final serum dilution inhibiting viral
cytopathic effects (CPE) with 100 or 250 TCID50 of virus. Serum
neutralization test was performed in microtiter plates using fetal
equine kidney (FEK) cells.

ND = Not determined.

Table 5 - Growth kinetics of EHV-1 in fetal donkey (FIDl) respiratory organ cultures

Titer of virus (Log^g TCID^g/O.025ml) in culture fluid* on given day after
inoculation_________________________________________________________________
Organ culture______0.5_______ 1________ 2________ 3________ 4________ 5________ 6_______ 7_______ 1_0
Nasal

1.1

2.7

3.5

2.6

1.8

1.2

1.2

Tracheal

2.4

3.8

2.8

1.6

1.0

0.6

0

*

Pool from 3 culture dishes;

1.0

ND

ND

each dish (60 x 15mm Petri dish) had received 0.5ml of a virus

suspension containing 10^"® TCID5g/0.025ml.

Virus titration was performed in fetal

equine kidney (FEK) monolayers in microtiter plates.

ND = Not determined.

1.2

Table

6

- Growth kinetics of EHV-1 in adult pony (Al) respiratory organ cultures

Titer of virus (Log^Q TCID^q /0.025ml) in culture fluid* on given day after
inoculation____________________________________________________________

Organ culture______ 0.5________ 1________ 2_________3________ 4________ 5_________ 6_________ 7_
Nasal

1.5

3.0

4.3

3.4

1.6

0.7

0.7

0

Tracheal

3.5

4.3

4.5

3.0

2.6

2.6

1.3

0

*

Pool from 3 culture dishes; each dish (60 x 15mm Petri dish) had received 0.5ml of a virus
suspension containing 106,6

T C I D 5 q / 0 .025ml.

Virus titration was performed in fetal

equine kidney monolayers in microtiter plates.

Table 7 - Growth kinetics of EHV-2 in fetal donkey (FlDl) respiratory organ cultures

Titer of virus (L° g i o t c i d 50/0.025ml) in culture fluid* on given day after
inoculation
Organ culture

0.5

1

2

3

4

5

6

7

10

14

20

30

Nasal

1.5

1.5

2.4

2.4

2.7

2.5

2.3

2.0

2.4

2.5

2.0

1.7

ND

2.0

2.5

2.5

2.5

2.5

2.5

ND

ND

ND

ND

ND

Tracheal

*

Pool from 3 culture dishes; each dish (60 x 15mm Petri dish) had received 0.5ml of a virus
suspension containing 106 ’3

T C I D 5 0 / O . 025ml.

Virus titration was performed in fetal

equine kidney (FEK) monolayers in microtiter plates.

ND = Not determined.

Table 8 - Growth kinetics of EHV-2 in fetal pony (FlMl) respiratory organ cultures

Titer of virus (Log^Q TC1D 50/o. 025ml) in culture fluid* on given day after
inoculation
2

3

4

5

6

7

10

14

2.6

2.8

3.0

3.9

2.6

3.7

2.8

2.8

3.7

3.5

2.6

2.0

1.5

1.6

0

0.7

1.4

2.2

0.8

1.8

2.0

2.2

0.9

0.6

0

0

0

0

0

Organ culture

0.5 -

1

Nasal

2.7

Tracheal
Pharyngeal

*

Pool from 4 culture dishes; each dish (60 x 15mm Petri dish) had received 0.5ml of a virus
suspension containing 10^'2 TCIDjg/O.025ml.

Virus titration was performed in fetal

equine kidney (FEK) monolayers in microtiter plates.

Table 9 - Growth kinetics of EHV-2 in adult pony (Al) respiratory organ cultures

Titer of virus (LogjO TCID^q /O.025ml) in culture fluid* on given day
after inoculation____________________________________________________________
Organ culture______ 1________ 2________ 3________ 4________ 5________ 6________ 7_______ 10_______ 14
Nasal

0.7

0

0

0

0

0

0.7

0

0.6

Tracheal

2.0

0.8

1.4

1.8

1.8

1.2

0.6

0

0

*

Pool from 3 culture dishes;

each dish (60 x 15mm Petri dish) had received 0.5ml of a virus

suspension containing 10^'^ TCIDj q /O.025ml.

Virus titration was performed in fetal

equine kidney (FEK) monolayers in microtiter plates.

Table 10 - Ciliary activity of EHV-1 infected fetal donkey (FIDl) respiratory organ cultures

No. of cultures with mot ile cilia on given day after inoculation
with virus
Organ culture

0*

1

2

3

4

5

6

7

8

Nasal
Infected (n = 6 sections)

6

6

6

6

6

4

3

2

0

7

7

7

7

7

7

7

7

7

6

6

3

3

2

0

0

0

0

7

7

7

7

7

5

5

4

1

Uninfected (n = 7 sections)

Tracheal
Infected (n = 6 rings)
Uninfected (n = 7 rings)

*

Prior to inoculation with virus.

Table 11 - Ciliary activity of EHV-1 infected adult pony (Al) respiratory organ cultures

No. of cultures with motile cilia on given day after inoculation
with virus
Organ culture

0*

1

2

3

4

5

6

7

8

Nasal
Infected (n = 6 sections)

6

4

0

0

0

0

0

0

0

6

4

3

2

2

2

2

2

2

6

6

6

6

6

3

0

0

0

6

6

6

6

6

6

6

2

1

Uninfected (n = 6 sections)

Tracheal
Infected (n = 6 rings)
Uninfected (n = 6 rings)

*

Prior to inoculation with virus.

Table 12 - Ciliary activity of EHV-2 infected fetal donkey (FlDl) respiratory organ cultures

No. of cultures with motile cilia on given day after inoculation
with virus
Organ culture
Nasal
Infected (n = 6 sections)
Uninfected (n = 7 sections)

Tracheal
Infected (n = 6 rings)
Uninfected (n = 7 rings)

*

0*

2

4

6

8

10

12

14

16

20

30

31

6

6

6

6

6

6

4

4

3

2

1

0

7

7

7

7

7

7

7

7

7

7

7

7

6

4

4

0

0

0

0

0

0

0

0

0

7

7

7

5

1

0

0

0

0

0

0

0

Prior to inoculation with virus.

Table 13 - Ciliary activity of EHV-2 infected adult pony (Al) respiratory organ cultures

No. of cultures with motile cilia on given day after inoculation
with virus
Organ culture

0*

1

2

3

4

5

6

7

8

Nasal
Infected (n = 6 sections)

6

5

4

4

3

2

1

u

0

6

4

-3

2

2

2

2

2

2

6

6

6

6

6

6

4

1

0

6

6

6

6

6

6

6

2

1

Uninfected (n = 6 sections)

Tracheal
Infected (n = 6 rings)
Uninfected (n = 6 rings)

*

Prior to inoculation with virus.

Table 14 - Time of cessation (days) of ciliary activity in > 50% of uninfected and equine herpesvirus
infected respiratory organ cultures.*

Virus
Organ culture

Control

EHV-2

EHV-1

2

4

2

Pony fetus (FlMl)

>14

14

ND

Donkey Fetus (FlDlJ

>3!

15

6

7

7

5

>14

>14

ND

8

5

3

Nasal
Pony adult (Al)

Tracheal
Pony adult (Al)
Pony fetus (FlMl)
Donkey fetus (FlDl)

*

Organ cultures were infected with 0.5ml per culture dish of an EHV-1 suspension containing 10®*®
TCID50/0*025ml and of an EHV-2 suspension containing approximately 10®*^ TCID50/0.025 ml.

ND = Not determined.
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SUMMARY
Cell cultures of equine alveolar macrophages and
respiratory organ cultures (nasal, pharyngeal, tracheal) were
inoculated with equine herpesvirus type 1 (EHV-1) or type 2
(EHV-2).

The two viruses and their interactions with the cell

and organ cultures were studied by transmission and scanning
electron microscopy.
By transmission electron microscopy capsids of EHV-1 and
EHV-2 were found to be morphologically similar to each other
and to those of other herpesviruses.

Typical herpesvirus

morphogenesis was seen in thin sections of EHV-2 infected nasal
organ cultures and virus was released into intercellular
spaces.
Scanning electron microscopy revealed that cytopathic
changes in EHV-1 and EHV-2 infected macrophage cultures con
sisted of rounding of cells and their retraction from the
substrate. Spherical particles assumed to be EHV-1 and EHV-2
virions were observed budding from the plasma membrane of
macrophages.
Cytopathic alterations produced by EHV-1 and EHV-2 were
observed in the epithelial layer of organ cultures.

EHV-1

induced alterations in nasal and tracheal cultures were ob
served within 48 hours post inoculation (HPI) and were charac
terized by rounding and lysis of epithelial cells. EHV-2
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induced surface changes were observed as early as 48 HPI in
pharyngeal cultures and 96 HPI in nasal and tracheal cultures.
The changes in pharyngeal cultures consisted initially of
extensive desquamation of pharyngeal epithelial cells, and
later of cell rounding.

Infected nasal and tracheal cultures

displayed cell rounding and loss of ciliated and non-ciliated
cells.

INTRODUCTION
Equine herpesvirus type 1 (EHV-1) and type 2 (EHV-2) have
been associated with some acute respiratory tract infections of
horses,

1-4

but little documentation of the pathogenic mecha

nisms involved in such infections is available.

Acute EHV-1

respiratory disease in foals is characterized by fever,
anorexia, profuse serous nasal discharge, necrosis of
epithelial cells of the upper respiratory tract accompanied by
an inflammatory response, and occasionally, a bronchopneumo
nia.^

Clinical and pathologic features almost identical to

those of EHV-1 infection have been reported for EHV-2 infection
3
in foals.
Some workers have reported that a chronic
pharyngitis with follicular proliferation in pharyngeal walls
may develop in foals after EHV-2 infection.^
Several workers have utilized organ cultures in
pathogenesis investigations to study respiratory viruses
including rhinoviruses, influenza viruses, parainfluenza
viruses, togaviruses, coronaviruses and herpesviruses.

6—12

Transmission electron microscopy (TEM) has been used to study
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ultrastructural characteristics of viruses and virus infected
cells, and scanning electron microscopy (SEM) has been used to
study surface topography of such systems.

The purpose of the

present report was to use TEM and SEM to observe internal and
surface features of cell and organ cultures infected with EHV-1
and EHV-2.

MATERIALS AND METHODS
Viruses
Reference strains of EHV-1 and EHV-2 were obtained from
Dr. J.E. Pearson, National Animal Disease Center, Ames, Iowa.
Their passage histories have been described (Chapter 1).
Cell cultures
Rabbit kidney epithelial cell line LLC-RK^ was used to
propagate EHV-1 and EHV-2 for negative contrast TEM.

The

source and passage history of the cell line were as described
previously (Chapter 1).

Eagle's minimal essential medium

(Sigma Chemical Company, St. Louis, MO) supplemented with 10%
fetal bovine serum, 100 IU of potassium penicillin G and 100
meg of streptomycin sulfate/ml, and buffered to a final
concentration of lOmM NaHCO^ and 25mM HEPES (N-2-hydroxyethyl
piperazine-N-2-ethanesulfonic acid), pH 7.4, was employed as
growth medium.

LLC-RK^ cell monolayer cultures were grown in

2
roller bottles (850cm )(Corning Glass Works, Corning, NY).
Pony alveolar macrophage (FPAM) cultures were initiated
from a near-term pony fetus.

The preparation and propagation
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of alveolar macrophages have been described (Chapter 1).

FPAM

cultures were used in the second passage.
Virus inoculation of FPAM cultures
Confluent monolayers of FPAM on glass coverslips (1.2cm
diameter) in 60 mm plastic tissue culture dishes (Falcon
Labware Division, Oxnard, CA) were inoculated with 0.4 ml of
stock EHV-1 (approximately 5X10^ TCID,.q ) or EHV-2 (approximate
ly 3x10^ TCIDj.q ) per coverslip.

After absorption for 1 h at 37

C, the inoculum was removed and cell monolayers were washed
twice in. phosphate-buffered saline, pH 7.4, and 3 ml of growth
medium was added.
Organ cultures
Methods used in acquiring, initiating, and infecting fetal
(FlMl) and adult (Al) pony respiratory organ cultures (nasal,
pharyngeal, tracheal) were described (Chapter 1).

Briefly,

tracheal rings and sections of nasal and pharyngeal tissue were
inoculated with EHV-1 or EHV-2 and maintained in Leibovitz's
L-15 medium at 37 C for 14 days.
Electron Microscopy
For negative staining of EHV-1 or EHV-2, virus-infected
monolayer cultures of LLC-RK^ cells showing 75-95% CPE were
rapidly frozen and thawed twice in a dry ice-ethanol bath.
The virus-rich cellular suspension thus obtained was clarified
by centrifuging at 10,410g for 20 min in a Sorval refrigerated
centrifuge (Ivan Sorval, Inc, Newton, Conn).

The pellet

(consisting mainly of cellular debris) was discarded and the
virus-rich supernate was centrifuged at 53,900g for 2.5 h
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in a Beckman ultracentrifuge (Beckman Spinco division,
Palo Alto, CA).

The supernatant fluid was discarded, and the

virus-rich pellet was resuspended in 0.1 M Na^PO^ buffer, pH
7.2, and homogenized by vigorous shaking on a vortex mixer
(Scientific Industries, Inc, Bohemia, NY).

The virus prepara

tion was nebulized on carbon-coated grids, stained with 4%
phosphotungstic acid, dried under vacuum, and examined in Zeiss
EM-10 transmission electron microscope (Zeiss, Inc, New York).
For thin section electron microscopy, infected and unin
fected control organ culture samples were processed according
to the method of O'Niell et al,

13

with a slight modification.

Briefly, the samples were fixed for 1 h in a mixture of 2%
formaldehyde and 1.25% glutaraldehyde in 0.1 M sodium
cacodylate buffer, pH 7.4, containing 5% sucrose.

They were

post fixed in 1% osmium tetroxide, treated with 1% tannic acid
mordant for 1 h at ambient temperature, dehydrated through a
graded series of ethanol, and embedded in epon-araldite mix
ture.

Thin sections were stained sequentially with uranyl

acetate and lead citrate prior to examination with a Zeiss
EM-10 Transmission Electron Microscope at 80kV.
At various intervals, cell and organ culture samples were
fixed at ambient temperature for 30 min (FPAM) or 1 h (organ
cultures) in a mixture of 2% formaldehyde and 1.25% glutaralde
hyde in 0.1M sodium cacodylate buffer, pH 7.4, containing 5%
sucrose.

After post fixation in 1% osmium tetroxide for 1 h,

samples were gradually dehydrated in ethanol (30% to 100%),
processed for SEM as described by O'Niell et al 13 examined in
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an S150 MARK 2 scanning electron microscope (Cambridge
Instruments, Monsey, NY)

at an acceleration voltage of 20kV.

RESULTS
Capsid morphology and morphogenesis
Cursory examination of negative stained virus revealed
that capsids of EHV-1 and EHV-2 were spherical and
morphologically similar measuring approximately lOOnm in
diameter.

Each capsid consisted of ring-shaped capsomeres each

of which measured approximately 12nm in external diameter.
Three capsids of EHV-2 are shown (Fig la), and a capsid of the
virus is presented with capsomeres in radial arrays (Fig lb).
Capsids of EHV-1 are shown (Fig lc) one of which possesses
outer and middle capsid layers as well as an electron dense
core.

Enveloped virions were not observed in the negative

stain preparations.
Analysis of fetal (FlMl) nasal cultures at 4 days post
inoculation (DPI) by TEM showed EHV-2 capsids (mostly contain
ing dense cores) in the nucleus of infected cells (Fig 2).
Clusters of viral particles were observed in cytoplasmic
vacuoles and some of these were released into the extracellular
space together with an electron dense amorphous material (Figs
3 and 4).

Enveloped viral particles had diameters that ranged

from 125 to about 150 nm.

A network of cytoplasmic fibrils

was observed in infected cells (Fig 5) and some of the fibrils
appeared to originate from the nucleus close to the nuclear
envelope (Fig 2).
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Surface alterations in virus infected FPAM.
Morphology of a normal second passage macrophage (FPAM)
monolayer by SEM is shown (Fig 6).

The flattened cells are

attached to the substrate and are in close contact with each
other.

In virus infected FPAM, cell rounding and retraction

from the substrate were first observed at 24 and 72 HPI for
EHV-1 and EHV-2 respectively (Figs 7 and 8). Several virus-like
particles with approximate diameters of 180 nm were seen on the
plasma membrane of cells infected with EHV-1 and EHV-2
respectively (Figs 9 and 10).
Surface alterations in virus infected organ cultures
Morphology of uninfected cultures:
The surface features of uninfected control nasal turbinate
epithelium as observed by SEM were essentially the same for
cultures derived from both fetal and adult equine sources.
Ciliated cells occurred in patches with the intervening spaces
occupied by non ciliated cells that had numerous microvilli.
Glandular openings were also interspersed in the epithelium
(Figs 11 and 12).

Uninfected control tracheal epithelium from

an adult pony (Al) had many furrows (Fig 13) as compared with
relatively few in that from fetal (FlMl) origin (Fig 14).

The

epithelium of fetal and adult tracheal rings were more uniform
ly ciliated than in nasal sections (Fig 15).

Control FlMl

pharyngeal epithelium (Fig 16) had numerous glandular openings
bordered by squamous epithelial cells.

At a high magnifica

tion, microplicae, or microfolds, were evident on squamous
epithelial cells (Fig 17).
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Morphology of EHV-1 Infected Al cultures:
EHV-1 induced surface changes were observed within 2 days
in infected nasal and tracheal cultures.

The changes which

increased in severity with time were characterized by rounding
and lysis of epithelial cells (Figs 18 and 19).

By 10 DPI,

many areas of the surface of infected nasal and tracheal
cultures were devoid of epithelial cells (Fig 20 and 21).

At

10 DPI rounded ciliated cells and cells with shortened cilia
were observed in infected tracheal epithelium
Ciliated and non ciliated cells

(Fig 22).

were absent from the

epithelium of infected tracheal cultures at 14 DPI and what
appears to be the basal lamina was exposed (Fig 23).

Morphology of EHV-2 infected FlMl cultures:
Pharyngeal epithelium

2 days after inoculation with EHV-2

(Fig 24) displays surface squamous epithelial cells in the
process of being desquamated.

At 4 DPI the epithelium was

elevated in areas of extensive cell rounding and probable cell
proliferation (Fig 25).

Such elevations

uninfected control cultures (Fig 26).

were absent in

AT 6 DPI, the fragile

upper layer of the stratified squamous epithelium of
both infected and uninfected pharyngeal cultures peeled off
during aldehyde fixation (not shown).
EHV-2 induced cytopathic changes in infected nasal cul
tures were first observed at 4 DPI.

The changes included

shedding of epithelial cells and cell rounding (Fig 27).

A

higher magnification of the central region of figure 27 (in
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legend and photo) revealed numerous spherical virus-like
particles which measured 140-190nm in diameter (Fig 28).
Extensive rounding and loss of epithelial cells were observed
at 14 DPI in infected nasal cultures (Fig 29), but ciliated
cells were still present (Fig 30).
Cytopathic changes in EHV-2 infected tracheal cultures
were observed as early as 4 DPI and consisted mainly of round
ing of epithelial cells (Fig 31).

At 6 DPI many foci of

rounded cells were observed (Fig 32), and by 14 DPI there was
widespread rounding of tracheal epithelial cells (Fig 33).

DISCUSSION
The upper and lower respiratory tract of horses is con
tinually cleansed by a mucociliary mechanism which traps
viruses and other particulate matter and transports them to the
pharyngeal region where they may be swallowed.

Virus particles

which bypass the cleansing system may reach the lung where they
may encounter alveolar macrophages and be phagocytosed.
Impairment of the mucociliary mechanism resulting from virus
infection may promote growth of secondary invaders such as
bacteria or other viruses.

Additional loss to respiratory

function could be caused by loss of phagocytic function of
alveolar macrophages as a result of virus multiplication and
persistence.
Organ cultures of portions of pony respiratory tract
(nasal, pharyngeal, tracheal) and monolayer cultures of pony
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alveolar macrophages (FPAM) were used in the present study to
investigate the pathogenesis of EHV-1 and EHV-2 infections.

To

date, there are no SEM and TEM studies of EHV-2 infections in
organ cultures, and only few reports are

available on the

ultrastructural relationship between EHV-1 and equine respi
ratory organ cultures.
Although host defense mechanisms such as immune and
inflammatory responses may be lacking in organ cultures, the
presence of live and fully differentiated cells in these
cultures suggest that the in vivo character is not completely
destroyed.

In organ cultures cells retain their normal

histological appearance and their functional activity as judged
by mucus production and ciliary activity.

Previous work has

shown that infections in organ cultures may closely approximate
what occurs in the intact animal.^**'*’

For example, in one

report growth of infectious bovine rhinotracheitis virus was
recorded in bovine tissues derived from various anatomic
locations. The greatest growth occurred in nasal, tracheal, and
vaginal epithelia, and the histopathological changes induced in
these cultures resembled those found in natural disease.^
Cytopathic effects were observed in this study following
infection of FPAM by both EHV-1 and EHV-2, and both viruses
also destroyed epithelium of the respiratory cultures.

The

magnitude and kinetics of cell damage varied between the two
viruses with EHV-2 being less cytopathic and taking more time
to produce equivalent histopathology. These results are in

104

agreement with the observation that EHV-2 exhibits delayed
cytopathology in cultured cells.^
Epithelial damage due to EHV-1 was severe and extensive.
This finding is consistent with a reported widespread necrosis
of epithelial cells in the upper respiratory tract in acutely
infected horses.

1

In SEM studies, O'Niell et al

13

did not

find ciliated cells at 6 DPI in EHV-1 infected fetal horse
tracheal cultures, whereas in the present study ciliated cells
were observed at 10 but not 14 DPI in infected adult pony (Al)
tracheal cultures.

The persistence of ciliated cells in

infected Al cultures for longer than 6 DPI could have been due
to the cultures having immune protection by virtue of being
derived from a seropositive donor. Another possibility is that
EHV-1 affects fetal respiratory tissue more severely than it
does adult respiratory tissue because virus specific receptors
may be present in larger numbers in fetal than in adult
respiratory tissue.

Alternatively, the cell metabolic

machinery in fetal tissues may be

more favorable to EHV-1

growth. Other contributory factors may be the absence of
mucosal immunity in fetal tissues due to lack of IgA producing
cells, although fetuses can produce IgM and IgG antibodies that
can act during the viremic stage of virus infections. Poor
interferon production

by fetal cells, or poor antimicrobial

responses of fetal phagocytic cells may also contribute to the
high susceptibility of fetal tissues to virus infection.
The extensive destruction of tracheal and nasal epithelia
by EHV-1 could result in the breakdown of an important
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component of the respiratory tract defense mechanism namely the
mucociliary clearance system.

The breakdown of this system may

allow more time for the attachment of bacteria to respiratory
tissue, and their subsequent multiplication in this site.
Also, following EHV-1 infection, bacterial-specific receptors
may be exposed on epithelial cells thus facilitating bacterial
adherence to these cells.

When these processes occur in vivo,

a severe bacterial pneumonia may result.
Epithelial damage due to EHV-2 was demonstrated in
pharyngeal, nasal and tracheal cultures.

EHV-2 morphogenesis

was also observed in thin sections of infected nasal cultures.
Replication of EHV-2 in respiratory organ cultures coupled with
the observed EHV-2 induced cytopathic changes in FPAM and organ
cultures suggest that EHV-2 is potentially pathogenic.

Surface

alterations in the organ cultures may be a pathologic basis for
the clinical signs seen after natural or experimental infect-

i 3,5
ions in young *
foals.
In SEM images of pharyngeal epithelial cells, interesting
surface structures were observed.

At higher magnification,

numerous ridge-like folds of the plasma membrane called
microplicae, or microfolds, could be distinguished.

Inter-

digitations of these microfolds among adjacent or overlying
cells may serve to organize the cells into sheets of stratified
epithelia. Since stratified epithelia are subject to wear and
tear, the microfolds may play a role in reducing the frictional
area between the plasma membranes of adjacent cells and in
trapping lubricating fluids such as mucin.^
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It has been proposed that superficial cells in stratified
epithelium can more easily desquamate than underlying cells.^
The explanation given was that in deeper layers of the
epithelium desmosomes are associated with many of the
microplicae whereas in the more superficial layers fewer
desmosomes are present.

As a result, adhesion is considerably

reduced among the superficial cells.

Viruses whose portal of

entry into a host does not involve the pharynx may be prevented
from establishing infection at this site by desquamation of
superficial cells.

This mechanism could account in part for

the observed clearance of EHV-2 from infected pharyngeal
cultures from post inoculation day 5 (Chapter 1).
The diameter of capsids of both EHV-1 and EHV-2 as
measured in electron micrographs of negative stain preparations
was approximately lOOnm, and the 12nm external diameter of the
ring-shaped capsomeres was similar to other herpesviruses.

18

Virions of EHV-1 and EHV-2 budding from the plasma membrane of
macrophages had an approximate diameter of 180nm.

Capsid

morphogenesis of EHV-2 was observed in the nucleus of infected
nasal epithleial cells but the process of envelopment at the
nuclear membrane was not seen. Several enveloped virions within
cytoplasmic vacuoles were present, and many were released
laterally into intercellular spaces and apically into the
culture medium.

This finding could explain the recovery of

EHV-2 in high amounts from infected cell and organ cultures
during the growth kinetic studies (Chapter 1).

107

Although some pathogenic properties of EHV-1 and EHV-2
have been demonstrated in the present work, future studies with
either of these agents should be coupled with animal experi
ments for a better appreciation of the pathogenic mechanisms
involved in respiratory virus infections. This will be espe
cially important for investigations involving diseases in which
immune and inflammatory responses play a significant role in
determining the outcome of infection.
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APPENDIX
Chapter II: Figures
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Abbreviations used in the figures:
EHV-1

=

Equine herpesvirus type 1

EHV-2

=

Equine herpesvirus type 2

FPAM

=

Fetal pony alveolar macrophage

F1M1

=

Fetal pony organ culture

A1

=

Adult pony organ culture

HPI

=

Hours post inoculation

DPI

=

Days post inoculation

TEM

=

Transmission electron microscopy

SEM

=

Scanning electron microscopy
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Fig 1 - Negatively stained EHV-1 and EHV-2 showing capsids without
an envelope.
a - Three capsids of EHV-2 illustrate the ring-like
capsomeres, morphological subunits of the viral
protein coat.
b - A capsid of EHV-2 shows capsomeres in radial array,
c - Capsids of EHV-1 are shown. One capsid (X) is
penetrated by phosphotungstic acid stain and reveals
outer and middle capsid layers. TEM,

a - bar = 50 nm; b - bar = 50 nm; c - bar = 50 nm.
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w-

Fig lb
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Fig 2 - EHV-2 infected F1M1 nasal epithelium at 4 DPI. Viral
morphogenesis is evident in this micrograph.

Nucleocapsids (large

arrows) are present in the nucleus (N) of an infected cell, and
viral particles (small arrows) are seen, outside the cell.
(F) in longitudinal and cross section are observed in the
cytoplasm (C) and they appear to be inserted in the nuclear
envelope (NE). TEM, bar = 0.5 pm.

Fibrils
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Safe

Fig 2
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Fig 3 - EHV-2 infected

F1M1 nasal epithelium at 4 DPI.

A cluster

of complete viral particles (large arrow) is being transported in
the cytoplasm of an infected cell.

Complete viral particles

(small arrows) and an amorphous material (A) are identified in the
micrograph. N = nucleus, C = cytoplasm, M = mitochondrion.

TEM,

bar = 0.5 ym.

Fig 4 - EHV-2 infected

F1M1 nasal epithelium at 4 DPI.

A cluster

of viral particles (same as in Fig 3) at high magnification,
illustrating details of virion morphology.

An incomplete particle

(arrow) appears sequestered in a separate vacuole.
= cytoplasm, M = mitochondrion.

TEM, bar = 0.5 ym.

N = nucleus, C
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Fig 4
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Fig 5 - EHV-2 infected F1M1 nasal epithelium at 4 DPI.
Intracytoplasmic fibrils (F) in longitudinal and cross section are
shown in two adjacent cells.

Two sites (large arrows) of viral

buds on the plasma membrane are indicated, and three complete
viral particles (small arrows) are seen at an intercellular
location.

TEM, bar = 0.5 pm.

Fig 6 - Surface view of uninfected FPAM monolayer.

Cells are

flattened, and in close contact with each other. SEM.

f

120

Fig

6
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Fig 7 - EHV-1 infected FPAM monolayer at 24 HPI.
changes consist of rounding of cells.

Cytopathic

In addition some cells have

extended long cytoplasmic processes (arrows) and are retracting
from the glass substrate. SEM.

Fig 8 - EHV-2 infected FPAM monolayer at 72 HPI.

Cells are in the

process of rounding, and a few of them are extending long
cytoplasmic processes (arrows).

Empty spaces (E) are observed in

areas of cell retraction from the glass substrate. SEM.

V

Fig 7

Fig

8
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Fig 9 - EHV-1 infected FPAM monolayer at 24 HPI. Viral particles
are present on the surface of an infected cell. SEM.

Fig 10 - EHV-2 infected FPAM monolayer at 72 HPI.

Fenestrations

(small arrows) representing areas of apparent plasma membrane
damage, and viral particles (large arrows) are prominent on the
surface of an infected cell. SEM.
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Fig 10
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Fig 11 - Surface view of uninfected F1M1 nasal epithelium at low
magnification. Ciliated cells (small arrows) and glandular
openings (large arrows) are interspersed in the epithelium. SEM.

Fig 12 - Surface view of uninfected F1M1 nasal epithelium at high
magnification.

Two types of cells are seen, non ciliated

polygonal cells with numerous microvilli (M), and cells possessing
cilia (C). A glandular opening (arrow) is identified.

f

SEM.
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Fig 12
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Fig 13 - Uninfected A1 tracheal epithelium at low magnification.
Many furrows are seen. SEM.

Fig 14 - Uninfected F1M1 tracheal epithelium at low magnification.
The epithelium is covered with a blanket of cilia.
of the tissue (arrow) is shown. SEM.

The cut edge
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Fig 14
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Fig 15 - Uninfected A1 tracheal epithelium at high magnification.
The epithelium is uniformly ciliated.

An opening

(arrow)of

tracheal gland is shown. SEM.

Fig 16 - Uninfected F1M1 pharyngeal epithelium at

low

magnification.

borderedby

The orifices of pharyngeal glands

squamous cells (arrows) are indicated in the micrograph. SEM.

a
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Fig 16
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Fig 17 - Uninfected F1M1 pharyngeal epithelium at high
magnification.

At this magnification, a pattern of folds (large

arrows) called microplicae is apparent on the surface of cells.
border (small arrows) between adjacent cells is identified. SEM.
i

Fig 18 - EHV-1 infected A1 nasal epithelium at 2 DPI.

Cell

rounding is seen as well as an area of apparent cell lysis
(arrow). SEM.

J

A
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Fig 17

40HM

Fig 18
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Fig 19 - EHV-1 infected A1 tracheal epithelium at 2 DPI.

Rounded

cells (large arrows) are seen, and the border (small arrows)
between an area of cytopathic alterations and one lacking such
changes is shown. SEM.

Fig 20 - EHV-1 infected A1 nasal epithelium at 10 DPI.
Epithelial cells are virtually absent leaving an exposed basement
membrane (B). Rounded cells (small arrows) in the process of
being shed, and openings (large arrows) of nasal glands are shown.
SEM.
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Fig 20
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Fig 21 - EHV-1 infected A1 tracheal epithelium at 10 DPI.
Ciliated cells (arrows) are lacking in parts of the epithelium,
and many of those present exhibit abnormal morphology as depicted
in Fig 22. SEM.

Fig 22 - EHV-1 infected A1 tracheal epithelium at 10 DPI.

A cell

(R) in the process of rounding manifests ciliary resorption or
arrested development of cilia. SEM.

136

Fig 22
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Fig 23 - EHV-1 infected A1 tracheal epithelium at 14 DPI.
Extensive loss of ciliated and non ciliated cells has occurred
leaving and exposed basement membrane (B). SEM.

Fig 24 - EHV-2 infected F1M1 pharyngeal epithelium at 2 DPI.

Many

regions of the epithelium display cells (arrows) in the process of
being shed by desquamation. SEM.
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Fig 24
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Fig 25 - EHV-2 infected F1M1 pharyngeal epithelium at 4 DPI.
Extensive degeneration and/or proliferation of cells are prominent
after virus infection, in contrast to minimal surface alterations
in uninfected control epithelium (Fig 26). SEM.

Fig 26 - Uninfected control F1M1 phayngeal epithelium at 4 DPI.
The epithelium displays minimal surface changes as compared with
that infected with EHV-2 (Fig 25). SEM.
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Fig 26
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Fig 27 - EHV-2 infected F1M1 nasal epithelium at 4 DPI. Various
cells are in the process of rounding.
enlarged in Fig 28.

The demarcated area is

CC = ciliated cell, NC = non ciliated cell,

RC = rounded cell, CM = cell with surface microvilli, 0 = opening
of nasal gland, SD = secretory droplets. SEM.

Fig 28 - EHV-2 infected F1M1 nasal epithelium at 4 DPI.

An

enlargement of the demarcated area in Fig 27 reveals many
virus-like particles or viral buds on the surface of infected
cells. SEM.
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Fig 28
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Fig 29 - EHV-2 infected F1M1 nasal epithelium at 14 DPI.
Extensive rounding of cells is evident.

Loss of ciliated and non

ciliated cells has occurred at various regions of the epithelium
leaving an exposed basement membrane (B). SEM.

Fig 30 - EHV-2 infected F1M1 nasal epithelium at 14 DPI.

A region

of the epithelium where the basement membrane is unexposed reveals
rounded cells and cells with attenuated cilia. SEM.

i
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Fig 30
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Fig 31 - EHV-2 infected F1M1 tracheal epithelium at 4 DPI.
Rounded cells (small arrows) and ciliated cells (large arrows) are
identified. SEM.

Fig 32 - EHV-2 infected F1M1 tracheal epithelium at 6 DPI.

Many

foci (F) of rounded cells and a few ciliated cells (arrows) are
present. SEM.
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Fig 31

Fig 32

Fig 33 - EHV-2 infected F1M1 tracheal epithelium at 14 DPI.
Rounding of epithelial cells is widespread. SEM.

Fig 33

CHAPTER III

EQUINE HERPESVIRUS TYPE 2:

KINETICS OF CYTOSKELETAL

AND CYTOPATHIC CHANGES IN PONY
ALVEOLAR MACROPHAGE CULTURES
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SUMMARY
Changes in the organization of microfilaments (MF) and
microtubules (MT) were studied by indirect immunofluorescence
microscopy and compared with the kinetics of cytopathic effects
(CPE) in monolayer cultures of pony alveolar macrophages
infected with equine herpesvirus type 2 (EHV-2).

In uninfected

cultures, MF were observed as parallel bundles of actin
filaments that ran from one end of a cell over the nucleus to
the other end, and MT appeared as pale radiating filaments that
seemed to originate from the nuclear region.

Cytoskeletal

changes after synchronized high multiplicity infection consisted
of the disruption of MF and MT (characterized by diffuse
staining of actin and tubulin) and a concomittant disappearance
of filaments.

Changes in the organization of MF and MT were

detected earlier than CPE (cell rounding and polykaryocytosis),
but at the time of appearance of CPE the same proportion of
cells in the monolayer displayed morphological alterations and
cytoskeletal changes.

From the onset of CPE, cytoskeletal and

cytopathic changes proceeded in parallel.
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INTRODUCTION
Infection of susceptible cultured cells with equine
herpesviruses results in the prodution of cytopathic effects
(CPE) manifested as cell rounding and, occasionally, syncytium
1 2

formation (polykaryocytosis). *

The underlying mechanisms of

virus-induced cell morphology changes remain largely unknown.
Results of previous studies suggest that cytoskeletal changes
may be involved in CPE and cell transformation.

3-11

Immunofluorescence microscopy has been used to study the
organization and distribution of microfilaments (MF) and
5 9-11
microtubules (MT) in normal and virus infected cells. '

The

present study was designed to examine and compare kinetics of
changes in the organization of MF and MT, and the production of
CPE in equine herpesvirus type 2 (EHV-2) infected pony alveolar
macrophages in vitro.
MATERIALS AND METHODS
Virus
The source of EHV-2 and propagation of the virus in rabbit
kidney (LLC-RK^) cells have been described (Chapter 1).
Cell cultures
The source and preparation of pony alveolar macrophages
were as described (Chapter 2).

Macrophages were grown as

monolayer cultures (4th subpassage) on Lab-Tek tissue culture
chamber slides (Lab-Tek Products, Miles Laboratories,
Inc, Naperville, Illinois).

Constituents of growth medium

for the cells were described (Chapter 1).
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Virus inoculation of macrophage monolayers
Macrophage monolayers on Lab-Tek 8-chamber slides were
inoculated with EHV-2 at a multiplicity of infection of
approximately 190.

After adsorption for 1 h at 37 C, the slides

were washed twice in Eagle's minimum essential medium containing
100 IU of potassium penicillin G and 100 meg of streptomycin
sulfate/ml, and 0.4 ml of growth medium was added to each
chamber.

Slides were maintained for various periods at 37 C in

a humidified incubator.
Immunoreagents
Pooled unabsorbed anti-actin and anti-tubulin antisera
raised in rabbits, and fluorescein isothiocyanate
(FITC)-conjugated goat anti-rabbit IgG were obtained from a
commerical source (Miles Scientific, Miles Laboratories, Inc,
Naperville,Illinois). Working dilutions of the reagents were
1:10 (anti-actin and anti-tubulin) and 1:16 (FITC-conjugated
anti-rabbit IgG).
Immunofluorescence
Cells in chambers of the Lab-Tek slides were processed for
indirect immunofluorescence as described by Saf.ake et al,

14

but

with a slight modification. The cells were fixed for 20 minutes
at ambient temperature in 4% formaldehyde in phosphate-buffered
saline(PBS), pH 7.4, and stored at 4C. Later, they were rinsed
in PBS and immersed in acetone: H^O (1:1) for 2 min, acetone for
5 min, and acetone: ^ 0

(1:1) for 2 min, all at -20C.

Cells

were incubated with the specific antibody(anti-actin or
anti-tubulin) at 37C for 1 h followed by FITC-conjugated
anti-rabbit IgG for 30 min.

The cells were examined with a
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Zeiss model 9901 photomicroscope (Zeiss, Inc, New York);
photographs were taken on Kodak Plus-X film.

RESULTS
Distribution of actin
Parallel bundles of actin filaments passing over the
nucleus and extending from one end of a cell to the other along
the major axes were seen in uninfected cultures (Fig 1).

At 36

hours post inoculation (HPI) with EHV-2, cells displayed intense
and diffused immunofluorescent staining and only few actin
filaments remained (Fig 2).

Also the cells appeared to retract

from the substrate and actin staining
periphery of cells.

was noted at the

At 72 HPI actin filaments essentially

disappeared and polykaryocytosis was noted(Fig 3).
Distribution of tubulin
The staining pattern of tubulin in uninfected cells
consisted of numerous pale filaments which appeared to radiate
out from the nuclear region and extend in parallel bundles along
the major cell axes (Fig 4). Tubulin staining was pale inside
the nucleus but more intense at the perinuclear area (Fig 4).
Infected cells at 36 HPI possessed fewer MT.(Fig 5).

At 72 HPI,

there was intense and diffuse tubulin staining in addition to
polykaryocytosis and disappearance of filaments

(Fig 6).

Kinetics of cytoskeletal and cytopathic changes
Disruption of the cytoskeleton after EHV-2 infection
occurred as early as 24

and 36 HPI for MF and MT respectively

and CPE (cell rounding and polykaryocytosis) were first noticed

154

at 48 HPI (Table 1).

At 48 HPI the proportion of monolayer

showing cytoskeletal and cytopathic changes was the same; from
this time, changes in organization of cytoskeletal elements and
CPE proceeded in parallel.

DISCUSSION

Immunofluorescence microscopy provides a simple and rapid
means of visualizing the cytoskeleton in large populations of
cells.

By this technique we have demonstrated disruption of two

cytoskeletal elements (microfilaments and microtubules) in
cultivated pony alveolar macrophages infected with EHV-2.
Changes in organization of cytoskeletal elements were detected
earlier than visible cytopathic effects (CPE).
Immunofluorescent staining patterns of MF and MT in the present
study are in agreement with those described previously in
transformed,^ virus-infected,*^ and uninfected cells.*"*
The variety of virus-induced cell changes termed CPE refer
mainly to those morphological changes observable at the level of
light microscopy.
virus strains.

The changes may vary for different viruses or

For example, poliovirus and vesicular stomatitis

virus cause cell rounding, whereas members of the paramyxovirus
group induce

polykaryocytosis as a result of cell fusion. ***

Infections with the Lennette strain of herpes simplex virus
(HSV)-l result in cell rounding while the IES strain of HSV-1
3
induces polykaryon formation.
EHV-2 caused both polykaryo
cytosis and cell rounding.
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The mechanism by which cell fusion is induced by EHV-2 is not
known. It has been proposed that herpesviruses demonstrate only
"fusion from within", that is, fusion resulting from de novo
synthesis of viral products, in contrast to "fusion from
without" which can occur without virus multiplication. Since
purified herpes virions have not been reported to cause fusion
of cells, it has been suggested that fusion may be caused by a
non-structural viral protein which appears on the surface of
infected cells.

16

In constrast to the limited knowledge of cell

fusion by herpesviruses, the paramyxovirus model of cell fusion
is widely studied and was reviewed by Schrom and Balanian.^
The envelope of paramyxoviruses contains two glycoproteins which
consist of spike-like projections on the surface of the virion.
One of the glycoprotein spikes, HN, is responsible for
receptor-binding (hemagglutinating) activity, while the other,
F, is responsible for fusion activity and associated activities
in cell penetration as well as hemolysis.
activated

The F polypeptide is

by a host protease to yield two fragments, F^ and F^

which remain associated by disulfide

bonds.

The cleavage

generated amino terminus of F^ appears to be responsible for the
fusion activity.
The involvement of MF and MT in virus-induced cell rounding
during transformation has been studied extensively but
relatively few studies have been carried out concerning the role
of the cytoskeleton in viral CPE.

Rounded transformed cells

have been shown in previous work to display a considerable
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reduction in the number of M T , ^ ’^

suggesting an inability of

these cells to assemble cytoplasmic MT and maintain normal cell
morphology.

The two main approaches employed to study the

relationship between cytoskeletal changes and CPE are the
microtubule

paracrystal (PC) and indirect immunofluor

escence assays.

The basis for the PC assay is that treatment of

cultured cells with vinblastine sulphate (a drug which binds
to the microtubule subunit tubulin) induces formation of large
microtubule paracrystals detectable under a phase-contrast
microscope.

17 18
8
’
Ebina et al reported that inhibition of PC

formation and the appearance of CPE (cell rounding and
disappearance of nucleoli) proceeded in parallel in HSV-infected
HeLa-S3 cells.

In the same report, these effects of HSV were

blocked by cycloheximide (a protein synthesis inhibitor) but not
by inhibitors of DNA synthesis.

The investigators concluded

that an "early" protein coded by the input virus genome
inhibited PC formation and was responsible for the CPE.

In

contrast to the observation of Ebina and coworkers, Heeg et al

3

observed vinblastine-induced PC in rabbit kidney cells infected
with HSV strains that produced either
polykaryocytosis.

cell rounding or

The difference was attributed to either the

cell type or the amount of virus used to initiate infection.
The authors also noted that virus replication was accompanied by
rearrangement of MT and production of CPE (polykaryocytosis) and
suggested that these effects were caused by early or late
virus-coded proteins.
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Howard et al

4

used antibodies against MF, MT, vimentin and

keratin filaments as immunofluorescent probes to compare
cytoskeletal organization in canine distemper virus (CDV)infected and uninfected Hep-2 cells.

Their study demonstrated

that CDV disrupted all the cytoskeletal elements and also
produced CPE (polykaryocytosis) in infected cells.

The

investigators were, however, unable to determine the order in
which cytoskeletal and cytopathic changes occurred as a kinetic
comparison was not performed.

In our study, disruption of MF

and MT were seen earlier than CPE, but at the time of
appearance of CPE the proportion of cell monolayer displaying
cytoskeletal and cytopathic changes was the same.
time, both changes proceeded in parallel.

After this

The utility of

cytoskeletal changes as opposed to CPE in detecting or
predicting infections by slowly cytopathic viruses such as EHV-2
and cytomegaloviruses may be suggested from our results.
In the present study both actin and tubulin staining were
observed in the cytoplasm of uninfected cells with intense
perinuclear distribution of tubulin while only tubulin
staining was detected in the nucleus.

It appears from these

observations that actin may be absent or present in very low
amounts in the nucleus.

Our results are somewhat in agreement

with previous immunofluorescence studies involving
cells.
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cycling

Actin and other microfilament associated proteins were

absent in the mitotic spindle but appeared during cytokinesis in
the cleavage furrow.

It was suggested that actin and

microfilament-associated proteins may not be a major constituent
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of the mitotic spindle. Brinkley et al ^

provided evidence for

two separate microtubule entities in cycling cells:

a

cytoplasmic microtubule complex, and microtubules of the mitotic
spindle.

Although an interchange of tubulin dimers was believed

to exist between MT in the nucleus and cytoplasm, control of MT
assembly was thought to be under separate constraints.

The

significance of nuclear MT in monolayer cultures of alveolar
macrophages having low cell turnover may need further
investigation.
Recently, .Sharp et al
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reported a reorganization of

vimentin filaments but not MT in reovirus infected monkey kidney
CV-1 cells indicating that not all components of the
cytoskeleton may be equally affected by all viruses. This
observation is in contrast to the findings of Howard et al

4

where both vimentin and MT were disrupted in Hep-2 cells after
infection with CDV. In the present study MT and MF were
disrupted in cultured pony alveolar macrophages infected with
EHV-2. It seems likely that the characteristics of the
individual virus may determine which cytoskeletal elements are
reorganized during cytocidal virus infections.

Probably tubulin

glycosylation or envelope-associated proteins specified by EHV-2
and CDV (enveloped viruses) may be responsible for
depolymerization of MT. Reoviruses (naked viruses) most likely
do not specify the synthesis of such proteins and therefore do
not cause disruption of MT.
The mechanism of virus-induced disruption of MT and MF in
cytocidal virus infections is unknown.

It is likely that
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virus-specified products may be involved.

These products could

behave in a manner similar to that of drugs which cause
depolymerization of MT and MF, or those that prevent assembly of
cytoskeletal subunits.

The two drugs colchicine and colcemid

(N-desacetyl-N-methyl colchicine) inhibit the assembly of
tubules and they are believed to form a complex with the free
tubulin dimer and interfere with its ability to polymerize,

21

in one study when 3T3 cells were treated with colcemid for 2h,
MT essentially disappeared or became greatly diminished, cells
lost their fibroblastic morphology and assumed a rounded and
knobby appearance.^ In another study, the sustained release of
insulin by cultured pancreatic cells was depressed when
colchicine was added to the culture medium.^

These experiments

suggest that MT are involved in maintenance of cell shape and
that they may also play an important role in intracellular
transport of secretory products.

Further studies are indicated

concerning the effect of metabolic inhibitors on the interaction
between EHV-2 and the cytoskeleton.

Results of such studies

will provide valuable insight into not only how CPE is produced
by cytocidal viruses, but also how cell shape and macromolecular
transport are controlled.
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APPENDIX
Chapter III: Figures and Table
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Abbreviations used in figures:
EHV-1

=

Equine herpesvirus type 1

EHV-2

=

Equine herpesvirus type 2

FPAM

=

Fetal pony alveolar macrophage

IF

=

Immunofluorescence microscopy
(anti-actin antibodies, anti-tubulin
antibodies, and FITC-conjugated anti-rabbit
IgG, all obtained from Miles Scientific
Laboratories Inc., Naperville, Illinois)

HPI

=

Hours post inoculation
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Fig 1 - Organization of actin in uninfected control FPAM
monolayer.

Note the parallel bundles of actin filaments (arrows)

running from one end of a cell to the other along the major axis
of the cell.

IF, bar = 20 pm.

Fig 2 - Organization of actin in EHV-2 infected FPAM monolayer at
36 HPI.

Note the disappearance of stainable actin filaments and

the concomittant increase in diffuse staining of actin.
20 pm.

IF, bar =
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Fig 2
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Fig 3 - Organization of actin in EHV-2 infected FPAM monolayer at
72 HPI.

Cell cytoplasm is essentially free of flourescent actin

filaments, while diffuse staining predominates.

IF, bar = 20 pm.

Fig 4 - Distribution of tubulin in uninfected control FPAM
monolayer.

Cytoplasmic microtubules in parallel arrangement

appear to originate from a perinuclear region that shows intense
tubulin staining.

IF, bar = 20 pm.
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Fig 3

Fig 4
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Fig 5 - Distribution of tubulin in EHV-2 infected FPAM monolayer
at 36 HPI.

Cytoplasmic microtubules have virtually disappeared,

but nuclear staining (arrows) is present.

IF, bar = 20 ym.

Fig 6 - Distribution of tubulin in EHV-2 infected FPAM monolayer
at 72 HPI.

Microtubules are essentially absent in cells, while

diffuse staining is prominent.
rounding.

IF, bar = 20 ym.

Note polykaryocytosis and cell
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Fig

6

Table 1 -

Kinetics of cytoskeletal changes and viral cytopathic effects (CPE)

__________ in EHV-2 infected equine alveolar macrophage cultures.*___________

Percentage of monolayer showing diffusely-stained cells**
Hours after infection

*

Microfilaments

Microtubules

24

10-25

<10

0

36

25-50

10-25

0

48

25-50

25-50

+

72

>95

>95

+++

96

>95

>95

+++

Monolayer macrophage cultures on Lab-tek chamber slides (Division Miles Labs, Inc., Naperville,
Illinois) were infected with EHV-2 at an input multiplicity of >_ 190.

**

Less than 10% of uninfected monolayer showed the diffused staining pattern in both
cases (microfilaments and microtubules).

#

CPE^

Rated as follows:

+ = 25%-50% of monolayer exhibited CPE, +++ = 75%-95% of

monolayer exhibited CPE.

COMPREHENSIVE DISCUSSION
The pathogenesis of equine herpesvirus type 2 (EHV-2)
respiratory infection was studied in cell and organ cultures by
infectivity assays following experimental infections (growth
kinetics), and by light, scanning and transmission electron
microscopy.

The kinetics of EHV-2 induced cytoskeletal and

cytopathic changes were investigated in monolayer cultures of
fetal pony alveolar macrophages (FPAM) by indirect
immunofluorescence microscopy.

Equine herpesvirus type 1

(EHV-1) was also studied to provide a comparative model for
EHV-2

infection.

were used:

Monolayer cultures of the following cells

fetal donkey alveolar macrophages (FDAM), fetal

equine (pony) kidney (FEK), rabbit kidney (LLC-RK^), and african
green monkey kidney (VERO). Organ cultures initiated from
respiratory tissues (nasal, tracheal, pharyngeal) of
seronegative pony (F1M1) and donkey (F1D1) fetuses, and a
seropositive adult pony (Al), were employed in the study,
EHV-2 multiplied in all the cell monolayers reaching peak
titers earlier in FEK and LLC-RK^ (72 hours post infection) than
in FDAM and VERO (96 hours post infection).

Since alveolar

macrophages play a pivotal role in pulmonary defense against
invading microorganisms, it was speculated that EHV-2
multiplication in these cells in vivo could impair their
phagocytic and other anti-microbial functions thereby promoting
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invasion of the lung by potentially pathogenic agents such as
bacteria.
The amount of EHV-2 released from the cell cultures was
higher (10-fold or more for the peak values) than that from
organ cultures. Two explanations could account for this
difference.

First, in organ cultures cell types differ and only

a relatively small proportion might be susceptible to infection.
Second, the beating of cilia could interfere with the process of
virus attachment after inoculation and allow for the entry of
only few viral particles into epithelial cells for virus
replication.
A further difference in the pattern of growth of EHV-2 in
cell and organ cultures was the

persistence of the virus in

infected nasal cultures for at least 14 days in F1M1 and 31 days
in F1D1, in contrast to the steady decline of EHV-2 titers after
attainment of peak values (3 to 4 days after inoculation) in the
cell cultures.

A possible explanation for EHV-2 persistence in

the organ cultures could be the production of interferon (IF) in
quantities sufficient to maintain an equilibrium between EHV-2
replication and IF concentration. In this case, EHV-2 could
stimulate certain nasal epithelial cells to produce IF, which in
turn may inhibit multiplication of the virus, resulting in
removal of the stimulus for further IF production.

The

subsequent decrease in IF concentration may allow virus
replication to occur which again stimulates the production of
IF, and the cycle continues.
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Growth of EHV-2 in nasal and tracheal cultures from the
different sources showed an inconsistent pattern.

In F1M1

cultures, the virus was released to higher peak titers (over
10-fold) in nasal than in tracheal cultures

whereas in F1D1

cultures peak EHV-2 titers were essentially the same for both
cultures.

In A1 cultures, EHV-2 was less readily released from

tracheal cultures and virus multiplication
nasal cultures.

was inhibited in the

It must be noted that all cell and organ

cultures were maintained at 37C in the present study and
interpretation of organ culture results especially must take
this into account as a temperature gradient exists in the
respiratory tract in vivo with a lower temperature in the nasal
region and a higher temperature in the tracheal region.

The

effect of temperature on virus multiplication in respiratory
organ cultures may require further investigation.
Multiplication of EHV-2 in F1M1 pharyngeal epithelium was
negligible although frequent isolation of the virus from
pharyngeal lymphoid follicles of infected horses have been
reported.

It was suggested that pharyngeal lymphoid follicles

of infected horses might represent the site of persistence of
EHV-2.

Although limited in scope, the present organ culture

findings are not consistent with this suggestion and seem to
implicate nasal epithelium as a more likely site of EHV-2
persistence with macrophages representing the secondary site of
persistence of the virus.

Constant sloughing of pharyngeal

cells in the superficial layers may serve to prevent infection
of the deeper layers of the stratified pharyngeal epithelium
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especially by viruses whose portal of entry may be other than
the pharynx.

On the other hand, blood-borne monocytes infected

with EHV-2 could transport the virus to the lymphoid follicles
of the pharynx where it may establish a persistent infection.
Nasal mucosal resistance plays a major role in upper
respiratory tract defense against microorganisms, as the nasal
cavity is the portal of entry for most respiratory viruses.

As

judged by EHV-2 multiplication in nasal organ cultures, it was
interesting to observe that cultures derived from F1M1 appeared
to be the most susceptible, followed by those from F1D1, and
then by A1 cultures which did not support the multiplication of
EHV-2.

Nevertheless, in organ cultures, immune and inflammatory

responses may be largely absent, and infections in these
cultures may not exactly represent what occurs in the intact
animal.

The above observations on the relative susceptibilities

indicate that age-dependent resistance may be significant in
EHV-2 infections, and in vivo studies may be required for
confirmation. Also, the role of serum neutralizing antibody and
nasal mucosal secretory IgA levels in protection of horses
against EHV-2 may need further investigation.
Morphogenesis of EHV-2 in F1M1 nasal organ cultures was
typical of members of the herpesvirus group.

Nucleocapsids of

the virus were observed in the nucleus of infected nasal
epithelial cells, and clusters of enveloped virions were seen in
cytoplasmic vacuoles and in extracellular spaces.

Negative

stain preparations of EHV-2 revealed single and double-shelled
capsids composed of ring-shaped capsomeres some of which were in
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radial arrays.

Enveloped particles were not observed in the

negative stain preparations probably due to the procedure used
which could have caused disruption and loss of the viral
envelope.
EHV-2 induced cytopathic changes in the cell monolayers
consisted of cell retraction and rounding, and syncytium
formation.

Changes in EHV-2 infected F1M1 organ cultures

consisted of rounding and shedding of ciliated and non-ciliated
epithelial cells.

A difference was observed in the two culture

systems in regard to the time of appearance of peak virus titers
and cytopathic changes.

In cell cultures cytopathic changes

preceeded peak virus titers by at least 24h
organ cultures the two parameters coincided.

whereas in the
Thus infection

patterns in cell and organ cultures exhibit significant
variations, and by coupling studies in both culture systems with
pathogenicity experiments in animals, much more useful
information may be obtained.
Cell morphology changes caused by EHV-2 were investigated
further by studying the kinetics of cytoskeletal and cytopathic
changes (cell rounding and syncytium formation) in FPAM.
Results indicated that cytopathic changes or CPE were subsequent
to changes in the organization of cellular microfilaments (MF)
and microtubules (MT).

It was suggested that these cytoskeletal

changes were better than CPE when employed for early detection
of infections by slowly cytopathic viruses such as EHV-2 and the
cytomegaloviruses.

Further studies on the mechanism of EHV-2

induced disruption of MT and MF involving the use of metabolic
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inhibitors were indicated.

Such investigation would be expected

to provide answers to not only how CPE is produced by cytocidal
viruses, but also how cell shape and intracellular transport of
macromolecules might be controlled.
In the present study, infection of nasal and tracheal
cultures by EHV-2 did not seem to exert a profound effect on
ciliary activity per se, but the observed EHV-2 induced
shedding of ciliated cells could impair the effectiveness of the
clearance of microbes or particulate matter by the mucociliary
defense mechanism.
In comparison with EHV-1, EHV-2 displayed slow growth and
delayed cytopathology in both cell and organ cultures. It is
noteworthy that in the cell cultures, EHV-2 attained slightly
higher peak titers than EHV-1 whereas in organ cultures the
reverse happened; EHV-1 was released to higher peak titers
(10-fold or more) than EHV-2.

It is possible that IF may be

partly responsible for the low EHV-2 titers in the organ
cultures whereas rapid multiplication and efficient release of
EHV-1 may have accounted for high titers of the virus in these
cultures.

In the cell cultures a more efficient release on a

per cell basis of EHV-2 may have occurred. In reference to
cytopathology, EHV-1 affected the cell and organ cultures more
severely causing extensive destruction of cell monolayers and
nasal and tracheal epithelia.
In general, the cell culture results confirmed the findings
of other investigators and the organ culture observations
appeared to lend support to previous in vivo findings, as
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discussed in the preceeding chapters.

Overall, the present

results seem to indicate that EHV-2 is potentially pathogenic
but less so than EHV-1, and that pathogenicity studies with
organ and cell cultures can extend our knowledge of viral
infections of the respiratory tract.
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